{"parse":{"title":"Pharmacovigilance","pageid":1243554,"revid":857207539,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">\"Drug safety\" redirects here. For the peer-reviewed journal, see <a href=\"/wiki/Drug_Safety\" title=\"Drug Safety\">Drug Safety</a>.</div>\n<table class=\"plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><div class=\"mw-collapsible\" style=\"width:95%; margin: 0.2em 0;\"><b>This article has multiple issues.</b> Please help <b><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve it</a></b> or discuss these issues on the <b><a href=\"/wiki/Talk:Pharmacovigilance\" title=\"Talk:Pharmacovigilance\">talk page</a></b>. <small><i>(<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove these template messages</a>)</i></small>\n<div class=\"mw-collapsible-content\" style=\"margin-top: 0.3em;\">\n      <table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-style\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Text_document_with_page_number_icon.svg\" class=\"image\"><img alt=\"Text document with page number icon.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Text_document_with_page_number_icon.svg/40px-Text_document_with_page_number_icon.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Text_document_with_page_number_icon.svg/60px-Text_document_with_page_number_icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Text_document_with_page_number_icon.svg/80px-Text_document_with_page_number_icon.svg.png 2x\" data-file-width=\"48\" data-file-height=\"48\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article cites its <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">sources</a> but <b>its <a href=\"/wiki/Wikipedia:Citing_sources#What_information_to_include\" title=\"Wikipedia:Citing sources\">page references</a> ranges are too broad</b>.<span class=\"hide-when-compact\"> Page ranges should be limited to one or two pages when possible. You can <a href=\"/wiki/Wikipedia:WikiProject_Fact_and_Reference_Check\" title=\"Wikipedia:WikiProject Fact and Reference Check\">help improve this article</a> by introducing citations that are more precise.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Original_research\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article  <b>possibly contains <a href=\"/wiki/Wikipedia:No_original_research\" title=\"Wikipedia:No original research\">original research</a></b>.<span class=\"hide-when-compact\"> Please <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve it</a> by <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verifying</a> the claims made and adding <a href=\"/wiki/Wikipedia:Citing_sources#Inline_citations\" title=\"Wikipedia:Citing sources\">inline citations</a>. Statements consisting only of original research should be removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n    </div>\n</div><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><b>Pharmacovigilance</b> (<b>PV</b> or <b>PhV</b>), also known as <b>drug safety</b>, is the <a href=\"/wiki/Pharmacology\" title=\"Pharmacology\">pharmacological</a> <a href=\"/wiki/Science\" title=\"Science\">science</a> relating to the <i>collection, detection, assessment, monitoring, and prevention</i> of <a href=\"/wiki/Adverse_effect_(medicine)\" class=\"mw-redirect\" title=\"Adverse effect (medicine)\">adverse effects</a> with <a href=\"/wiki/Pharmaceutical_drug\" class=\"mw-redirect\" title=\"Pharmaceutical drug\">pharmaceutical products</a>.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>  The <a href=\"/wiki/Etymological\" class=\"mw-redirect\" title=\"Etymological\">etymological</a> roots for the word \"pharmacovigilance\" are: <i>pharmakon</i> (Greek for drug) and <i>vigilare</i> (Latin for to keep watch).  As such, pharmacovigilance heavily focuses on <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">adverse drug reactions</a>, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the <a href=\"/wiki/Prophylaxis\" class=\"mw-redirect\" title=\"Prophylaxis\">prophylaxis</a>, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation).<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>  <a href=\"/wiki/Medication_error\" class=\"mw-redirect\" title=\"Medication error\">Medication errors</a> such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>Information received from patients and healthcare providers via pharmacovigilance agreements (PVAs), as well as other sources such as the <a href=\"/wiki/Medical_literature\" title=\"Medical literature\">medical literature</a>, plays a critical role in providing the data necessary for pharmacovigilance to take place.  In fact, in order to market or to test a pharmaceutical product in most countries, adverse event data received by the license holder (usually a pharmaceutical company) must be submitted to the local drug regulatory authority.  <i>(See <a href=\"#Adverse_event_reporting\">Adverse event reporting</a> below.)</i>\n</p><p>Ultimately, pharmacovigilance is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. Companies must conduct a comprehensive drug safety and pharmacovigilance audit to assess their compliance with worldwide laws, regulations, and guidance.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Terms_commonly_used_in_drug_safety\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Terms commonly used in drug safety</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Adverse_event_reporting\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Adverse event reporting</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Individual_Case_Safety_Report_(ICSR)\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Individual Case Safety Report (ICSR)</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Coding_of_adverse_events\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Coding of adverse events</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Seriousness_determination\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Seriousness determination</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Expedited_reporting\"><span class=\"tocnumber\">2.4</span> <span class=\"toctext\">Expedited reporting</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Clinical_trial_reporting\"><span class=\"tocnumber\">2.5</span> <span class=\"toctext\">Clinical trial reporting</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Spontaneous_reporting\"><span class=\"tocnumber\">2.6</span> <span class=\"toctext\">Spontaneous reporting</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Aggregate_reporting\"><span class=\"tocnumber\">2.7</span> <span class=\"toctext\">Aggregate reporting</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Other_reporting_methods\"><span class=\"tocnumber\">2.8</span> <span class=\"toctext\">Other reporting methods</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Risk_management\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Risk management</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Causality_assessment\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Causality assessment</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Signal_detection\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Signal detection</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Risk_management_plans\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Risk management plans</span></a></li>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#Risk/benefit_profile_of_drugs\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Risk/benefit profile of drugs</span></a></li>\n<li class=\"toclevel-2 tocsection-16\"><a href=\"#Pharmacoepidemiology\"><span class=\"tocnumber\">3.5</span> <span class=\"toctext\">Pharmacoepidemiology</span></a></li>\n<li class=\"toclevel-2 tocsection-17\"><a href=\"#Pharmacogenetics_and_pharmacogenomics\"><span class=\"tocnumber\">3.6</span> <span class=\"toctext\">Pharmacogenetics and pharmacogenomics</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#International_collaboration\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">International collaboration</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-19\"><a href=\"#The_World_Health_Organization_(WHO)\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">The World Health Organization (WHO)</span></a></li>\n<li class=\"toclevel-2 tocsection-20\"><a href=\"#The_International_Council_for_Harmonisation_(ICH)\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">The International Council for Harmonisation (ICH)</span></a></li>\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#The_Council_for_International_Organizations_of_Medical_Science_(CIOMS)\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">The Council for International Organizations of Medical Science (CIOMS)</span></a></li>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#The_International_Society_of_Pharmacovigilance_(ISoP)\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">The International Society of Pharmacovigilance (ISoP)</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-23\"><a href=\"#Regulatory_authorities\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Regulatory authorities</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#United_States\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">United States</span></a></li>\n<li class=\"toclevel-2 tocsection-25\"><a href=\"#Emerging_economies_(including_Latin_America)\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Emerging economies (including Latin America)</span></a></li>\n<li class=\"toclevel-2 tocsection-26\"><a href=\"#European_Union\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">European Union</span></a></li>\n<li class=\"toclevel-2 tocsection-27\"><a href=\"#Rest_of_Europe,_including_non-EU\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Rest of Europe, including non-EU</span></a></li>\n<li class=\"toclevel-2 tocsection-28\"><a href=\"#Japan\"><span class=\"tocnumber\">5.5</span> <span class=\"toctext\">Japan</span></a></li>\n<li class=\"toclevel-2 tocsection-29\"><a href=\"#Canada\"><span class=\"tocnumber\">5.6</span> <span class=\"toctext\">Canada</span></a></li>\n<li class=\"toclevel-2 tocsection-30\"><a href=\"#South_Korea\"><span class=\"tocnumber\">5.7</span> <span class=\"toctext\">South Korea</span></a></li>\n<li class=\"toclevel-2 tocsection-31\"><a href=\"#Africa\"><span class=\"tocnumber\">5.8</span> <span class=\"toctext\">Africa</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-32\"><a href=\"#Kenya\"><span class=\"tocnumber\">5.8.1</span> <span class=\"toctext\">Kenya</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-33\"><a href=\"#Rest_of_world_(ROW)\"><span class=\"tocnumber\">5.9</span> <span class=\"toctext\">Rest of world (ROW)</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-34\"><a href=\"#Pharmacoenvironmentology;_(Ecopharmacovigilance_[EPV])\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Pharmacoenvironmentology; (Ecopharmacovigilance [EPV])</span></a></li>\n<li class=\"toclevel-1 tocsection-35\"><a href=\"#Related_to_medical_devices\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Related to medical devices</span></a></li>\n<li class=\"toclevel-1 tocsection-36\"><a href=\"#For_herbal_medicines\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">For herbal medicines</span></a></li>\n<li class=\"toclevel-1 tocsection-37\"><a href=\"#Industry_associations\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Industry associations</span></a></li>\n<li class=\"toclevel-1 tocsection-38\"><a href=\"#See_also\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-39\"><a href=\"#References\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-40\"><a href=\"#External_links\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Terms_commonly_used_in_drug_safety\">Terms commonly used in drug safety</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=1\" title=\"Edit section: Terms commonly used in drug safety\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Unreferenced\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>does not <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">cite</a> any <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">sources</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this section</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href=\"/wiki/Wikipedia:Verifiability#Burden_of_evidence\" title=\"Wikipedia:Verifiability\">removed</a>.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>Pharmacovigilance has its own unique terminology that is important to understand.  Most of the following terms are used within this article and are peculiar to drug safety, although some are used by other disciplines within the pharmaceutical sciences as well.\n</p>\n<ul><li><i><a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">Adverse drug reaction</a> </i> is a side effect (non intended reaction to the drug) occurring with a drug where a positive (direct) causal relationship between the event and the drug is thought, or has been proven, to exist.</li>\n<li><i><a href=\"/wiki/Adverse_event\" title=\"Adverse event\">Adverse event</a> (AE)</i> is a side effect occurring with a drug.  By definition, the causal relationship between the AE and the drug is unknown.</li>\n<li><i><a href=\"/wiki/Health_benefit_(medicine)\" class=\"mw-redirect\" title=\"Health benefit (medicine)\">Benefits</a></i> are commonly expressed as the proven <a href=\"/wiki/Therapeutic\" class=\"mw-redirect\" title=\"Therapeutic\">therapeutic</a> good of a product but should also include the patient's subjective assessment of its effects.</li>\n<li><i><a href=\"/wiki/Causal_relationship\" class=\"mw-redirect\" title=\"Causal relationship\">Causal relationship</a></i> is said to exist when a drug is thought to have caused or contributed to the occurrence of an adverse drug reaction.</li>\n<li><i><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a></i> (or study) refers to an organised program to determine the safety and/or <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> of a drug (or drugs) in patients.  The design of a clinical trial will depend on the drug and the phase of its development.</li>\n<li><i>Control group</i> is a group (or cohort) of individual patients that is used as a standard of comparison within a clinical trial.  The control group may be taking a placebo (where no active drug is given) or where a different active drug is given as a comparator.</li>\n<li><i>Dechallenge</i> and <i><a href=\"/wiki/Rechallenge\" class=\"mw-redirect\" title=\"Rechallenge\">rechallenge</a></i> refer to a drug being stopped and restarted in a patient, respectively.  A positive dechallenge has occurred, for example, when an adverse event abates or resolves completely following the drug's discontinuation.  A positive rechallenge has occurred when the adverse event re-occurs after the drug is restarted.  Dechallenge and rechallenge play an important role in determining whether a causal relationship between an event and a drug exists.</li>\n<li><i><a href=\"/wiki/Effectiveness\" title=\"Effectiveness\">Effectiveness</a></i> is the extent to which a drug works under real world circumstances, i.e., clinical practice.</li>\n<li><i><a href=\"/wiki/Efficacy\" title=\"Efficacy\">Efficacy</a></i> is the extent to which a drug works under ideal circumstances, i.e., in clinical trials.</li>\n<li><i>Event</i> refers to an adverse event (AE).</li>\n<li><i><a href=\"/wiki/Harm\" title=\"Harm\">Harm</a></i> is the nature and extent of the actual damage that could be or has been caused.</li>\n<li><i>Implied causality</i> refers to spontaneously reported AE cases where the causality is always presumed to be positive unless the reporter states otherwise.</li>\n<li><i>Individual Case Safety Report (ICSR)</i> is an adverse event report for an individual patient.</li>\n<li><i>Life-threatening</i> refers to an adverse event that places a patient at the <i>immediate</i> risk of death.</li>\n<li><i>Phase</i> refers to the four <a href=\"/wiki/Phases_of_clinical_research\" title=\"Phases of clinical research\">phases of clinical research</a> and development: I \u2013 small safety trials early on in a drug's development; II \u2013 medium-sized trials for both safety and efficacy; III \u2013 large trials, which includes key (or so-called \"pivotal\") trials; IV \u2013 large, post-marketing trials, typically for safety reasons.  There are also intermediate phases designated by an \"a\" or \"b\", e.g. Phase IIb.</li>\n<li><i><a href=\"/wiki/Risk\" title=\"Risk\">Risk</a></i> is the probability of harm being caused, usually expressed as a percent or ratio of the treated population.</li>\n<li><i><a href=\"/wiki/Risk_factor\" title=\"Risk factor\">Risk factor</a></i> is an attribute of a patient that may predispose, or increase the risk, of that patient developing an event that may or may not be drug-related.  For instance, obesity is considered a risk factor for a number of different diseases and, potentially, ADRs. Others would be high blood pressure, diabetes, possessing a specific mutated gene, for example, mutations in the <a href=\"/wiki/BRCA1\" title=\"BRCA1\">BRCA1</a> and BRCA2 genes increase propensity to develop breast cancer.</li>\n<li><i>Signal</i> is a new safety finding within safety data that requires further investigation.  There are three categories of signals: <i>confirmed signals</i> where the data indicate that there is a causal relationship between the drug and the AE; <i>refuted</i> (or false) signals where after investigation the data indicate that no causal relationship exists; and <i>unconfirmed</i> signals which require further investigation (more data) such as the conducting of a post-marketing trial to study the issue.</li>\n<li><i>Temporal relationship</i> is said to exist when an adverse event occurs when a patient is taking a given drug.  Although a temporal relationship is absolutely necessary in order to establish a causal relationship between the drug and the AE, a temporal relationship does not necessarily in and of itself prove that the event was caused by the drug.</li>\n<li><i><a href=\"/wiki/Triage\" title=\"Triage\">Triage</a></i> refers to the process of placing a potential adverse event report into one of three categories: 1) non-serious case; 2) serious case; or 3) no case (minimum criteria for an AE case are not fulfilled).</li></ul>\n<h2><span class=\"mw-headline\" id=\"Adverse_event_reporting\">Adverse event reporting</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=2\" title=\"Edit section: Adverse event reporting\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>The activity that is most commonly associated with pharmacovigilance (PV), and which consumes a significant amount of resources for drug regulatory authorities (or similar government agencies) and drug safety departments in pharmaceutical companies, is that of adverse event reporting.  Adverse event (AE) reporting involves the receipt, triage, data entering, assessment, distribution, reporting (if appropriate), and archiving of AE data and documentation.  The source of AE reports may include: spontaneous reports from healthcare professionals or patients (or other intermediaries); solicited reports from patient support programs; reports from clinical or post-marketing studies; reports from literature sources; reports from the media (including social media and websites); and reports reported to drug regulatory authorities themselves.  For pharmaceutical companies, AE reporting is a regulatory requirement in most countries.  AE reporting also provides data to these companies and drug regulatory authorities that play a key role in assessing the risk-benefit profile of a given drug.  The following are several facets of AE reporting:\n</p>\n<h3><span id=\"Individual_Case_Safety_Report_.28ICSR.29\"></span><span class=\"mw-headline\" id=\"Individual_Case_Safety_Report_(ICSR)\">Individual Case Safety Report (ICSR)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=3\" title=\"Edit section: Individual Case Safety Report (ICSR)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>One of the fundamental principles of adverse event reporting is the determination of what constitutes an Individual Case Safety Report (ICSR).  During the triage phase of a potential adverse event report, it is important to determine if the \"four elements\" of a valid ICSR are present: (1) an identifiable patient, (2) an identifiable reporter, (3) a suspect drug, and (4) an adverse event.\n</p><p>If one or more of these four elements is missing, the case is not a valid ICSR.  Although there are no exceptions to this rule there may be circumstances that may require a judgment call.  For example, the term \"identifiable\" may not always be clear-cut.  If a physician reports that he/she has a patient X taking drug Y who experienced Z (an AE), but refuses to provide any specifics about patient X, the report is still a valid case even though the patient is not specifically identified.  This is because the reporter has first-hand information about the patient and is <i>identifiable</i> (i.e. a real person) to the physician.  Identifiability is important so as not only to prevent duplicate reporting of the same case, but also to permit follow-up for additional information.\n</p><p>The concept of identifiability also applies to the other three elements.  Although uncommon, it is not unheard of for fictitious adverse event \"cases\" to be reported to a company by an anonymous individual (or on behalf of an anonymous patient, disgruntled employee, or former employee) trying to damage the company's reputation or a company's product.  In these and all other situations, the source of the report should be ascertained (if possible).  But anonymous reporting is also important, as whistle blower protection is not granted in all countries. In general, the drug must also be specifically named. Note that in different countries and regions of the world, drugs are sold under various tradenames. In addition, there are a large number of generics which may be mistaken for the trade product. Finally, there is the problem of counterfeit drugs producing adverse events. If at all possible, it is best to try to obtain the sample which induced the adverse event, and send it to either the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">EMA</a>, FDA or other government agency responsible for investigating AE reports.\n</p><p>If a reporter can't recall the name of the drug they were taking when they experienced an adverse event, this would not be a valid case.  This concept also applies to adverse events.  If a patient states that they experienced \"symptoms\", but cannot be more specific, such a report might technically be considered valid, but will be of very limited value to the pharmacovigilance department of the company or to drug regulatory authorities.<sup id=\"cite_ref-Pharmacovigilance_p_V_5-0\" class=\"reference\"><a href=\"#cite_note-Pharmacovigilance_p_V-5\">&#91;5&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Coding_of_adverse_events\">Coding of adverse events</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=4\" title=\"Edit section: Coding of adverse events\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Adverse event coding is the process by which information from an AE reporter, called the \"verbatim\", is coded using standardized terminology from a medical coding dictionary, such as <a href=\"/wiki/MedDRA\" title=\"MedDRA\">MedDRA</a> (the most commonly used medical coding dictionary).  The purpose of medical coding is to convert adverse event information into terminology that can be readily identified and analyzed.  For instance, Patient 1 may report that they had experienced \"a very bad headache that felt like their head was being hit by a hammer\" [Verbatim 1] when taking Drug X.  Or, Patient 2 may report that they had experienced a \"slight, throbbing headache that occurred daily at about two in the afternoon\" [Verbatim 2] while taking Drug Y.  Neither Verbatim 1 nor Verbatim 2 will exactly match a code in the MedDRA coding dictionary.  However, both quotes describe different manifestations of a headache.  As a result, in this example both quotes would be coded as PT Headache (PT = Preferred Term in MedDRA).\n</p>\n<h3><span class=\"mw-headline\" id=\"Seriousness_determination\">Seriousness determination</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=5\" title=\"Edit section: Seriousness determination\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Although somewhat intuitive, there are a set of criteria within pharmacovigilance that are used to distinguish a serious adverse event from a non-serious one.  An adverse event is considered serious if it meets one or more of the following criteria:\n</p>\n<ol><li>results in death, or is life-threatening;</li>\n<li>requires inpatient hospitalization or prolongation of existing hospitalization;</li>\n<li>results in persistent or significant disability or incapacity;</li>\n<li>results in a congenital anomaly (birth defect); or</li>\n<li>is otherwise \"medically significant\" (i.e., that it does not meet preceding criteria, but is considered serious because treatment/intervention would be required to prevent one of the preceding criteria.)<sup id=\"cite_ref-Pharmacovigilance_p_V_5-1\" class=\"reference\"><a href=\"#cite_note-Pharmacovigilance_p_V-5\">&#91;5&#93;</a></sup></li></ol>\n<p>Aside from death, each of these categories is subject to some interpretation.  Life-threatening, as it used in the drug safety world, specifically refers to an adverse event that places the patient at an <i>immediate risk of death</i>, such as cardiac or respiratory arrest.  By this definition, events such as <a href=\"/wiki/Myocardial_infarction\" title=\"Myocardial infarction\">myocardial infarction</a>, which would be hypothetically life-threatening, would not be considered life-threatening unless the patient went into cardiac arrest following the MI.  Defining what constitutes hospitalization can be problematic as well.  Although typically straightforward, it's possible for a hospitalization to occur even if the events being treated are not serious.  By the same token, serious events may be treated without hospitalization, such as the treatment of anaphylaxis may be successfully performed with epinephrine.  Significant disability and incapacity, as a concept, is also subject to debate.  While permanent disability following a stroke would no doubt be serious, would \"complete blindness for 30 seconds\" be considered \"significant disability\"?  For birth defects, the seriousness of the event is usually not in dispute so much as the attribution of the event to the drug. Finally, \"medically significant events\" is a category that includes events that may be always serious, or sometimes serious, but will not fulfill any of the other criteria.  Events such as cancer might always be considered serious, whereas liver disease, depending on its CTCAE (Common Terminology Criteria for Adverse Events) grade\u2014Grades 1 or 2 are generally considered non-serious and Grades 3-5 serious\u2014may be considered non-serious.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Expedited_reporting\">Expedited reporting</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=6\" title=\"Edit section: Expedited reporting\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>This refers to ICSRs (individual case safety reports) that involve a serious and unlisted event (an event not described in the drug's labeling) that is considered related to the use of the drug.  (Spontaneous reports are typically considered to have a positive causality, whereas a clinical trial case will typically be assessed for causality by the clinical trial investigator and/or the license holder.) In most countries, the timeframe for reporting expedited cases is 7/15 calendar days from the time a drug company receives notification (referred to as \"Day 0\") of such a case.  Within clinical trials such a case is referred to as a SUSAR (a Suspected Unexpected Serious Adverse Reaction).  If the SUSAR involves an event that is life-threatening or fatal, it may be subject to a 7-day \"clock\".  Cases that do not involve a serious, unlisted event may be subject to non-expedited or periodic reporting.\n</p>\n<h3><span class=\"mw-headline\" id=\"Clinical_trial_reporting\">Clinical trial reporting</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=7\" title=\"Edit section: Clinical trial reporting\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Also known as SAE (serious adverse event) reporting from clinical trials, safety information from clinical studies is used to establish a drug's safety profile in humans and is a key component that drug regulatory authorities consider in the decision-making as to whether to grant or deny market authorization (market approval) for a drug.  SAE reporting occurs as a result of study patients (subjects) who experience serious adverse events during the conducting of clinical trials.  (Non-serious adverse events are also captured separately.)  SAE information, which may also include relevant information from the patient's medical background, are reviewed and assessed for causality by the study investigator.  This information is forwarded to a sponsoring entity (typically a pharmaceutical company) that is responsible for the reporting of this information, as appropriate, to drug regulatory authorities.\n</p>\n<h3><span class=\"mw-headline\" id=\"Spontaneous_reporting\">Spontaneous reporting</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=8\" title=\"Edit section: Spontaneous reporting\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Spontaneous reports are termed spontaneous as they take place during the clinician's normal diagnostic appraisal of a patient, when the clinician is drawing the conclusion that the drug may be implicated in the causality of the event.\nSpontaneous reporting system relies on vigilant physicians and other healthcare professionals who not only generate a suspicion of an ADR, but also report it. It is an important source of regulatory actions such as taking a drug off the market or a label change due to safety problems.\nSpontaneous reporting is the core data-generating system of international pharmacovigilance, relying on healthcare professionals (and in some countries consumers) to identify and report any adverse events to their national pharmacovigilance center, health authority (such as <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">EMA</a> or FDA), or to the drug manufacturer itself.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> Spontaneous reports are, by definition, submitted voluntarily although under certain circumstances these reports may be encouraged, or \"stimulated\", by media reports or articles published in medical or scientific publications, or by product lawsuits. In many parts of the world adverse event reports are submitted electronically using a defined message standard.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p><p>One of the major weaknesses of spontaneous reporting is that of under-reporting, where, unlike in clinical trials, less than 100% of those adverse events occurring are reported.  Further complicating the assessment of adverse events, AE reporting behavior varies greatly between countries and in relation to the seriousness of the events, but in general probably less than 10% (some studies suggest less than 5%) of all adverse events that occur are actually reported.  The rule-of-thumb is that on a scale of 0 to 10, with 0 being least likely to be reported and 10 being the most likely to be reported, an uncomplicated non-serious event such as a mild headache will be closer to a \"0\" on this scale, whereas a life-threatening or fatal event will be closer to a \"10\" in terms of its likelihood of being reported.  In view of this, medical personnel may not always see AE reporting as a priority, especially if the symptoms are not serious. And even if the symptoms are serious, the symptoms may not be recognized as a possible side effect of a particular drug or combination thereof. In addition, medical personnel may not feel compelled to report events that are viewed as expected.  This is why reports from patients themselves are of high value. The confirmation of these events by a healthcare professional is typically considered to increase the value of these reports. Hence it is important not only for the patient to report the AE to his health care provider (who may neglect to report the AE), but also report the AE to both the biopharmaceutical company and the FDA, EMA, ... This is especially important when one has obtained one's pharmaceutical from a compounding pharmacy.\n</p><p>As such, spontaneous reports are a crucial element in the worldwide enterprise of pharmacovigilance and form the core of the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> Database, which includes around 4.6&#160;million reports (January 2009),<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> growing annually by about 250,000.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Aggregate_reporting\">Aggregate reporting</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=9\" title=\"Edit section: Aggregate reporting\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Aggregate reporting, also known as periodic reporting, plays a key role in the safety assessment of drugs.  Aggregate reporting involves the compilation of safety data for a drug over a prolonged period of time (months or years), as opposed to single-case reporting which, by definition, involves only individual AE reports.  The advantage of aggregate reporting is that it provides a broader view of the safety profile of a drug.  Worldwide, the most important aggregate report is the Periodic Safety Update Report (PSUR) and Development Safety Update Report (DSUR).  This is a document that is submitted to drug regulatory agencies in Europe, the US and Japan (ICH countries), as well as other countries around the world.  The PSUR was updated in 2012 and is now referred to in many countries as the Periodic Benefit Risk Evaluation report (PBRER).  As the title suggests, the PBRER's focus is on the benefit-risk profile of the drug, which includes a review of relevant safety data compiled for a drug product since its development.\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_reporting_methods\">Other reporting methods</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=10\" title=\"Edit section: Other reporting methods\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Some countries legally oblige spontaneous reporting by physicians. In most countries, manufacturers are required to submit, through its <a href=\"/wiki/Qualified_Person_for_Pharmacovigilance\" class=\"mw-redirect\" title=\"Qualified Person for Pharmacovigilance\">Qualified Person for Pharmacovigilance</a> (QPPV), all of the reports they receive from healthcare providers to the national authority. Others have intensive, focused programmes concentrating on new drugs, or on controversial drugs, or on the prescribing habits of groups of doctors, or involving pharmacists in reporting. All of these generate potentially useful information. Such intensive schemes, however, tend to be the exception.\n</p>\n<h2><span class=\"mw-headline\" id=\"Risk_management\">Risk management</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=11\" title=\"Edit section: Risk management\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><a href=\"/wiki/Risk_management\" title=\"Risk management\">Risk management</a> is the discipline within pharmacovigilance that is responsible for signal detection and the monitoring of the risk-benefit profile of drugs.  Other key activities within the area of risk management are that of the compilation of <a href=\"/wiki/Risk_management_plan\" title=\"Risk management plan\">risk management plans</a> (RMPs) and aggregate reports such as the Periodic Safety Update Report (PSUR), Periodic Benefit-Risk Evaluation Report (PBRER), and the Development Safety Update Report (DSUR).\n</p>\n<h3><span class=\"mw-headline\" id=\"Causality_assessment\">Causality assessment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=12\" title=\"Edit section: Causality assessment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>One of the most important, and challenging, problems in pharmacovigilance is that of the determination of causality.  Causality refers to the relationship of a given adverse event to a specific drug.  Causality determination (or assessment) is often difficult because of the lack of clear-cut or reliable data.  While one may assume that a positive temporal relationship might \"prove\" a positive causal relationship, this is not always the case.  Indeed, a \"bee sting\" AE\u2014where the AE can clearly be attributed to a specific cause\u2014is by far the exception rather than the rule.  This is due to the complexity of human physiology as well as that of disease and illnesses.  By this reckoning, in order to determine causality between an adverse event and a drug, one must first exclude the possibility that there were other possible causes or contributing factors. If the patient is on a number of medications, it may be the combination of these drugs which causes the AE, and not any one individually. There have been a number of recent high-profile cases where the AE led to the death of an individual. The individual(s) were not overdosed with any one of the many medications they were taking, but the combination there appeared to cause the AE. Hence it is important to include in your/one's AE report, not only the drug being reported, but also all other drugs the patient was also taking.\n</p><p>For instance, if a patient were to start Drug X and then three days later were to develop an AE, one might be tempted to attribute blame Drug X.  However, before that can be done, the patient's medical history would need to be reviewed to look for possible risk factors for the AE.  In other words, did the AE occur with the drug or <i>because</i> of the drug?  This is because a patient on any drug may develop or be diagnosed with a condition that could not have possibly been caused by the drug.  This is especially true for diseases, such as cancer, which develop over an extended period of time, being diagnosed in a patient who has been taken a drug for a relatively short period of time.  On the other hand, certain adverse events, such as blood clots (thrombosis), can occur with certain drugs with only short-term exposure.  Nevertheless, the determination of risk factors is an important step of confirming or ruling-out a causal relationship between an event and a drug.\n</p><p>Often the only way to confirm the existence of a causal relationship of an event to a drug is to conduct an observational study where the incidence of the event in a patient population taking the drug is compared to a control group.  This may be necessary to determine if the background incidence of an event is less than that found in a group taking a drug.  If the incidence of an event is statistically significantly higher in the \"active\" group versus the placebo group (or other control group), it is possible that a causal relationship may exist to a drug, unless other confounding factors may exist.\n</p>\n<h3><span class=\"mw-headline\" id=\"Signal_detection\">Signal detection</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=13\" title=\"Edit section: Signal detection\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Signal_detection\" class=\"mw-redirect\" title=\"Signal detection\">Signal detection</a> (SD) involves a range of techniques (CIOMS VIII). The WHO defines a safety signal as: \"Reported information on a possible causal relationship between an adverse event and a drug, the relationship being unknown or incompletely documented previously\". Usually more than a single report is required to generate a signal, depending upon the event and quality of the information available.\n</p><p>Data mining pharmacovigilance databases is one approach that has become increasingly popular with the availability of extensive data sources and inexpensive computing resources. The data sources (databases) may be owned by a pharmaceutical company, a drug regulatory authority, or a large healthcare provider. Individual Case Safety Reports (ICSRs) in these databases are retrieved and converted into structured format, and statistical methods (usually a mathematical algorithm) are applied to calculate statistical measures of association. If the statistical measure crosses an arbitrarily set threshold, a signal is declared for a given drug associated with a given adverse event. All signals deemed worthy of investigation, require further analysis using all available data in an attempt to confirm or refute the signal.  If the analysis is inconclusive, additional data may be needed such as a post-marketing observational trial.\n</p><p>SD is an essential part of drug use and  safety surveillance. Ideally, the goal of SD is to identify ADRs that were previously considered unexpected and to be able to provide guidance in the product's labeling as to how to minimize the risk of using the drug in a given patient population.\n</p>\n<h3><span class=\"mw-headline\" id=\"Risk_management_plans\">Risk management plans</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=14\" title=\"Edit section: Risk management plans\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A risk management plan (RMP) is a documented plan that describes the risks (adverse drug reactions and potential adverse reactions) associated with the use of a drug and how they are being handled (warning on drug label or on packet inserts of possible side effects which if observed should cause the patient to inform/see his physician and/or pharmacist and/or the manufacturer of the drug and/or the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a>, <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">EMA)</a>).  The overall goal of an RMP is to assure a positive risk-benefit profile once the drug is (has been) marketed.  The document is required to be submitted, in a specified format, with all new market authorization requests within the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> (EU).  Although not necessarily required, RMPs may also be submitted in countries outside the EU.  The risks described in an RMP fall into one of three categories: identified risks, potential risks, and unknown risks.  Also described within an RMP are the measures that the Market Authorization Holder, usually a pharmaceutical company, will undertake to minimize the risks associated with the use of the drug.  These measures are usually focused on the product's labeling and healthcare professionals.  Indeed, the risks that are documented in a pre-authorization RMP will inevitably become part of the product's post-marketing labeling.  Since a drug, once authorized, may be used in ways not originally studied in clinical trials, this potential \"<a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label use</a>\", and its associated risks, is also described within the RMP.  RMPs can be very lengthy documents, running in some cases hundreds of pages and, in rare instances, up to a thousand pages long.\n</p><p>In the US, under certain circumstances, the FDA may require a company to submit a document called a Risk Evaluation and Mitigation Strategies (REMS) for a drug that has a specific risk that FDA believes requires mitigation.  While not as comprehensive as an RMP, a REMS can require a sponsor to perform certain activities or to follow a protocol, referred to as Elements to Assure Safe Use (ETASU),<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> to assure that a positive risk-benefit profile for the drug is maintained for the circumstances under which the product is marketed.\n</p>\n<h3><span id=\"Risk.2Fbenefit_profile_of_drugs\"></span><span class=\"mw-headline\" id=\"Risk/benefit_profile_of_drugs\">Risk/benefit profile of drugs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=15\" title=\"Edit section: Risk/benefit profile of drugs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Pharmaceutical companies are required by law in most countries to perform <a href=\"/wiki/Clinical_trials\" class=\"mw-redirect\" title=\"Clinical trials\">clinical trials</a>, testing new drugs on people before they are made generally available.  This occurs after a drug has been pre-screened for toxicity, sometimes using animals for testing.  The manufacturers or their agents usually select a representative sample of patients for whom the drug is designed \u2013 at most a few thousand \u2013 along with a comparable control group. The control group may receive a placebo and/or another drug, often a so-called \"gold standard\" that is \"best\" drug marketed for the disease.\n</p><p>The purpose of clinical trials is to determine:\n</p>\n<ul><li>if a drug works and how well it works</li>\n<li>if it has any harmful effects, and</li>\n<li>if it does more good than harm, and how much more? If it has a potential for harm, how probable and how serious is the harm?</li></ul>\n<p>Clinical trials do, in general, tell a good deal about how well a drug works. They provide information that should be reliable for larger populations with the same characteristics as the trial group \u2013 age, gender, state of health, ethnic origin, and so on though target clinical populations are typically very different from trial populations with respect to such characteristics<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (June 2017)\">citation needed</span></a></i>&#93;</sup>.\n</p><p>The variables in a clinical trial are specified and controlled, but a clinical trial can never tell you the whole story of the effects of a drug in all situations. In fact, nothing could tell you the whole story, but a clinical trial must tell you enough; \"enough\" being determined by legislation and by contemporary judgements about the acceptable balance of benefit and harm.  Ultimately, when a drug is marketed it may be used in patient populations that were not studied during clinical trials (children, the elderly, pregnant women, patients with co-morbidities not found in the clinical trial population, etc.) and a different set of warnings, precautions or contraindications (where the drug should not be used at all) for the product's labeling may be necessary in order to maintain a positive risk/benefit profile in all known populations using the drug.\n</p>\n<h3><span class=\"mw-headline\" id=\"Pharmacoepidemiology\">Pharmacoepidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=16\" title=\"Edit section: Pharmacoepidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n<p><a href=\"/wiki/Pharmacoepidemiology\" title=\"Pharmacoepidemiology\">Pharmacoepidemiology</a> is the study of the incidence of adverse drug reactions in patient populations using drug agents.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Pharmacogenetics_and_pharmacogenomics\">Pharmacogenetics and pharmacogenomics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=17\" title=\"Edit section: Pharmacogenetics and pharmacogenomics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Although often used interchangeably, there are subtle differences between the two disciplines.  <a href=\"/wiki/Pharmacogenetics\" title=\"Pharmacogenetics\">Pharmacogenetics</a> is generally regarded as the study or clinical testing of genetic variation that gives rise to differing responses to drugs, including adverse drug reactions.  It is hoped that pharmacogenetics will eventually provide information as to which genetic profiles in patients will place those patients at greatest risk, or provide the greatest benefit, for using a particular drug or drugs.  <a href=\"/wiki/Pharmacogenomics\" title=\"Pharmacogenomics\">Pharmacogenomics</a>, on the other hand, is the broader application of genomic technologies to new drug discovery and further characterization of older drugs.\n</p>\n<h2><span class=\"mw-headline\" id=\"International_collaboration\">International collaboration</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=18\" title=\"Edit section: International collaboration\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>The following organizations play a key collaborative role in the global oversight of pharmacovigilance.\n</p>\n<h3><span id=\"The_World_Health_Organization_.28WHO.29\"></span><span class=\"mw-headline\" id=\"The_World_Health_Organization_(WHO)\">The World Health Organization (WHO)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=19\" title=\"Edit section: The World Health Organization (WHO)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The principle of international collaboration in the field of pharmacovigilance is the basis for the WHO Programme for International Drug Monitoring, through which over 150 member nations have systems in place that encourage healthcare personnel to record and report adverse effects of drugs in their patients.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> These reports are assessed locally and may lead to action within the country. Since 1978, the programme has been managed by the <a href=\"/wiki/Uppsala_Monitoring_Centre\" title=\"Uppsala Monitoring Centre\">Uppsala Monitoring Centre</a> to which member countries send their reports to be processed, evaluated and entered into an international database called <a href=\"/wiki/VigiBase\" title=\"VigiBase\">VigiBase</a>. Membership in the WHO Programme enables a country to know if similar reports are being made elsewhere.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> When there are several reports of adverse reactions to a particular drug, this process may lead to the detection of a signal, and an alert about a possible hazard communicated to members countries after detailed evaluation and expert review.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span id=\"The_International_Council_for_Harmonisation_.28ICH.29\"></span><span class=\"mw-headline\" id=\"The_International_Council_for_Harmonisation_(ICH)\">The International Council for Harmonisation (ICH)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=20\" title=\"Edit section: The International Council for Harmonisation (ICH)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The ICH is a global organization with members from the European Union, the United States and Japan; its goal is to recommend global standards for drug companies and drug regulatory authorities around the world, with the ICH Steering Committee (SC) overseeing harmonization activities. Established in 1990, each of its six co-sponsors\u2014the EU, the European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan's Ministry of Health, Labor and Welfare (MHLW), the Japanese Pharmaceutical Manufacturers Association (JPMA), the U.S. Food and Drug Administration (FDA), and the Pharmaceutical Research and Manufacturers of America (PhRMA)\u2014have two seats on the SC. Other parties have a significant interest in ICH and have been invited to nominate Observers to the SC; three current observers<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Dates_and_numbers#Chronological_items\" title=\"Wikipedia:Manual of Style/Dates and numbers\"><span title=\"The time period mentioned near this tag is ambiguous. (March 2014)\">when?</span></a></i>&#93;</sup> are the WHO, <a href=\"/wiki/Health_Canada\" title=\"Health Canada\">Health Canada</a>, and the <a href=\"/wiki/European_Free_Trade_Association\" title=\"European Free Trade Association\">European Free Trade Association</a> (EFTA), with the International Federation of Pharmaceutical Manufacturers Association (IFPMA) participating as a non-voting member of the SC.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p>\n<h3><span id=\"The_Council_for_International_Organizations_of_Medical_Science_.28CIOMS.29\"></span><span class=\"mw-headline\" id=\"The_Council_for_International_Organizations_of_Medical_Science_(CIOMS)\">The Council for International Organizations of Medical Science (CIOMS)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=21\" title=\"Edit section: The Council for International Organizations of Medical Science (CIOMS)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The CIOMS, a part of the WHO, is a globally oriented <a href=\"/wiki/Think_tank\" title=\"Think tank\">think tank</a> that provides guidance on drug safety related topics through its Working Groups.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> The CIOMS prepares reports that are used as a reference for developing future drug regulatory policy and procedures, and over the years, many of CIOMS' proposed policies have been adopted.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>  Examples of topics these reports have covered include: Current Challenges in Pharmacovigilance: Pragmatic Approaches (CIOMS V); Management of Safety Information from Clinical Trials (CIOMS VI); the Development Safety Update Report (DSUR): Harmonizing the Format and Content for Periodic Safety Reporting During Clinical Trials (CIOMS VII); and Practical Aspects of Signal Detection in Pharmacovigilance: Report of CIOMS Working Group (CIOMS VIII).<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span id=\"The_International_Society_of_Pharmacovigilance_.28ISoP.29\"></span><span class=\"mw-headline\" id=\"The_International_Society_of_Pharmacovigilance_(ISoP)\">The International Society of Pharmacovigilance (ISoP)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=22\" title=\"Edit section: The International Society of Pharmacovigilance (ISoP)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The ISoP is an international non-profit scientific organization, which aims to foster pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> It was established in 1992 as the European Society of Pharmacovigilance.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Regulatory_authorities\">Regulatory authorities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=23\" title=\"Edit section: Regulatory authorities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>Drug regulatory authorities play a key role in national or regional oversight of pharmacovigilance. Some of the agencies involved are listed below (in order of 2011 spending on pharmaceuticals, from the IMS Institute for Healthcare Informatics).<sup id=\"cite_ref-forbes.com_20-0\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"United_States\">United States</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=24\" title=\"Edit section: United States\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/Regulation_of_therapeutic_goods_in_the_United_States\" title=\"Regulation of therapeutic goods in the United States\">Regulation of therapeutic goods in the United States</a></div>\n<p>In the U.S., with about a third of all global 2011 pharmaceutical expenditures,<sup id=\"cite_ref-forbes.com_20-1\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> the drug industry is regulated by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a>, the largest national drug regulatory authority in the world.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> FDA authority is exercised through enforcement of regulations derived from legislation, as published in the U.S. <a href=\"/wiki/Code_of_Federal_Regulations\" title=\"Code of Federal Regulations\">Code of Federal Regulations</a> (CFR); the principal drug safety regulations are found in 21 CFR Part 312 (IND regulations) and 21 CFR Part 314 (NDA regulations).<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>  While those regulatory efforts address pre-marketing concerns,  pharmaceutical manufacturers and academic/non-profit organizations such as <a href=\"/wiki/Research_on_Adverse_Drug_events_And_Reports\" class=\"mw-redirect\" title=\"Research on Adverse Drug events And Reports\">RADAR</a> and <a href=\"/wiki/Public_Citizen\" title=\"Public Citizen\">Public Citizen</a> do play a role in pharmacovigilance in the US.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> The post-legislative rule-making process of the U.S. federal government provides for significant input from both the legislative and executive branches, which also play specific, distinct roles in determining FDA policy.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span id=\"Emerging_economies_.28including_Latin_America.29\"></span><span class=\"mw-headline\" id=\"Emerging_economies_(including_Latin_America)\">Emerging economies (including Latin America)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=25\" title=\"Edit section: Emerging economies (including Latin America)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The \"pharmerging\", or emerging pharmaceutical market economies, which include Brazil, India, Russia, Argentina, Egypt, Indonesia, Mexico, Pakistan, Poland, Romania, South Africa, Thailand, Turkey, Ukraine and Vietnam, accrued one fifth of global 2011 pharmaceutical expenditures; in future, aggregated data for this set will include China as well.<sup id=\"cite_ref-forbes.com_20-2\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup>\n</p><p>China's economy is anticipated to pass Japan to become second in the ranking of individual countries' in pharmaceutical purchases by 2015, and so its PV regulation will become increasing important; China's regulation of PV is through its National Center for Adverse Drug Reaction (ADR) Monitoring, under China's Ministry of Health.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p><p>As JE Sackman notes, as of April 2013 \"there is no Latin American equivalent of the European Medicines Agency\u2014no common body with the power to facilitate greater consistency across countries\".<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> For simplicity, and per sources, 17 smaller economies are discussed alongside the 4 pharmemerging large economies of Argentina, Brazil, Mexico and Venzuala\u2014Bolivia, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Panama, Paraguay, Peru, Suriname, and Uruguay.<sup id=\"cite_ref-vigilance2012_23-0\" class=\"reference\"><a href=\"#cite_note-vigilance2012-23\">&#91;23&#93;</a></sup> As of June 2012, 16 of this total of 21 countries have systems for immediate reporting and 9 have systems for periodic reporting of adverse events for on-market agents, while 10 and 8, respectively, have systems for immediate and periodic reporting of adverse events during clinical trials; most of these have PV requirements that rank as \"high or medium...in line with international standards\" (<i>ibid.</i>). The WHO's Pan American Network for Drug Regulatory Harmonization<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> seeks to assist Latin American countries in develop harmonized PV regulations.<sup id=\"cite_ref-vigilance2012_23-1\" class=\"reference\"><a href=\"#cite_note-vigilance2012-23\">&#91;23&#93;</a></sup>\n</p><p>Some further PV regulatory examples from the pharmerging nations are as follows. In India, the PV regulatory authority is the Indian Pharmacopoeia Commission, with a National Coordination Centre under the Pharmacovigilance Program of India, in the Ministry of Health and Family Welfare.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup><sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> Scientists working on pharmacovigilance share their experiences, findings, innovative ideas and researches during the annual meeting of <a href=\"/wiki/Society_of_Pharmacovigilance,_India\" title=\"Society of Pharmacovigilance, India\">Society of Pharmacovigilance, India</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> In Egypt, PV is regulated by the Egyptian Pharmacovigilance Center of the Egyptian Ministry of Health.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"European_Union\">European Union</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=26\" title=\"Edit section: European Union\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The EU5 (France, Germany, Italy, Spain, United Kingdom) accrued ~17% of global 2011 pharmaceutical expenditures.<sup id=\"cite_ref-forbes.com_20-3\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> PV efforts in the EU are coordinated by the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) and are conducted by the national competent authorities (NCAs).<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> The main responsibility of the EMA is to maintain and develop the pharmacovigilance database consisting of all suspected serious adverse reactions to medicines observed in the <a href=\"/wiki/European_Community\" class=\"mw-redirect\" title=\"European Community\">European Community</a>; the  data processing network and management system is called <a href=\"/wiki/EudraVigilance\" title=\"EudraVigilance\">EudraVigilance</a> and contains separate but similar databases of human and veterinary reactions.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> The EMA requires the individual marketing authorization holders to submit all received adverse reactions in electronic form, except in exceptional circumstances; the reporting obligations of the various stakeholders are defined by EEC legislation, namely <a href=\"/wiki/Regulation\" title=\"Regulation\">Regulation</a> (EC) No 726/2004, and for human medicines, <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a> <a href=\"/wiki/Directive_2001/83/EC\" title=\"Directive 2001/83/EC\">Directive 2001/83/EC</a> as amended and <a href=\"/wiki/Directive_2001/20/EC\" class=\"mw-redirect\" title=\"Directive 2001/20/EC\">Directive 2001/20/EC</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>  In 2002, Heads of Medicines Agencies<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> agreed on a mandate for an ad hoc Working Group on establishing a European risk management strategy; the Working Group considered the conduct of a high level survey of EU pharmacovigilance resources to promote the utilization of expertise and encourage collaborative working.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p><p>In conjunction with this oversight, individual countries maintain their distinct regulatory agencies with PV responsibility.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup>  For instance, in Spain, PV is regulated by the Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS), a legal entity that retains the right to suspend or withdraw the authorization of pharmaceuticals already on-market if the evidence shows that safety (or quality or efficacy) of an agent are unsatisfactory.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>\n</p>\n<h3><span id=\"Rest_of_Europe.2C_including_non-EU\"></span><span class=\"mw-headline\" id=\"Rest_of_Europe,_including_non-EU\">Rest of Europe, including non-EU</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=27\" title=\"Edit section: Rest of Europe, including non-EU\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n<p>The remaining EU and non-EU countries outside the EU5 accrued ~7% of global 2011 pharmaceutical expenditures.<sup id=\"cite_ref-forbes.com_20-4\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> Regulation of those outside the EU being managed by specific governmental agencies.  For instance, in Switzerland, PV \"inspections\" for clinical trials of medicinal products are conducted by the Swiss Agency for Therapeutic Products.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Japan\">Japan</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=28\" title=\"Edit section: Japan\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n<p>In Japan, with ~12% of all global 2011 pharmaceutical expenditures,<sup id=\"cite_ref-forbes.com_20-5\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> PV matters are regulated by the <a href=\"/wiki/Pharmaceuticals_and_Medical_Devices_Agency\" title=\"Pharmaceuticals and Medical Devices Agency\">Pharmaceuticals and Medical Devices Agency</a> (PMDA) and the Ministry of Health, Labour, and Welfare <a href=\"/wiki/MHLW\" class=\"mw-redirect\" title=\"MHLW\">MHLW</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Canada\">Canada</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=29\" title=\"Edit section: Canada\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n<p>In Canada, with ~2% of all global 2011 pharmaceutical expenditures,<sup id=\"cite_ref-forbes.com_20-6\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> PV is regulated by the Marketed Health Products Directorate of the Health Products and Food Branch (Health Canada).<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"South_Korea\">South Korea</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=30\" title=\"Edit section: South Korea\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n<p>The <a href=\"/wiki/Republic_of_Korea\" class=\"mw-redirect\" title=\"Republic of Korea\">Republic of Korea</a>, with ~1% of all global 2011 pharmaceutical expenditures,<sup id=\"cite_ref-forbes.com_20-7\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> PV matters are regulated in South Korea by the Ministry Of Food And Drug Safety (MFDS) and the Ministry of Health, Labour, and Welfare <a href=\"/wiki/MHLW\" class=\"mw-redirect\" title=\"MHLW\">MHLW</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Africa\">Africa</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=31\" title=\"Edit section: Africa\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"Kenya\">Kenya</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=32\" title=\"Edit section: Kenya\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In Kenya, PV is regulated by the <a href=\"/wiki/Pharmacy_and_Poisons_Board\" title=\"Pharmacy and Poisons Board\">Pharmacy and Poisons Board</a>.The <a href=\"/wiki/Pharmacy_and_Poisons_Board\" title=\"Pharmacy and Poisons Board\">Pharmacy and Poisons Board</a> provides a Pharmacovigilance Electronic Reporting System which allows for the online reporting of suspected adverse drug reactions as well as suspected poor quality of medicinal products.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup> The Pharmacovigilance activities in Kenya are supported by the School of Pharmacy, <a href=\"/wiki/University_of_Nairobi\" title=\"University of Nairobi\">University of Nairobi</a> through its Master of Pharmacy in Pharmacoepidemiology &amp; Pharmacovigilance program offered by the <a href=\"/w/index.php?title=Department_of_Pharmacology_and_Pharmacognosy&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Department of Pharmacology and Pharmacognosy (page does not exist)\">Department of Pharmacology and Pharmacognosy</a>.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup><br />\n</p><p>In Uganda, PV is regulated by the National Drug Authority.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h3><span id=\"Rest_of_world_.28ROW.29\"></span><span class=\"mw-headline\" id=\"Rest_of_world_(ROW)\">Rest of world (ROW)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=33\" title=\"Edit section: Rest of world (ROW)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n<p>ROW accrued ~7% of global 2011 pharmaceutical expenditures.<sup id=\"cite_ref-forbes.com_20-8\" class=\"reference\"><a href=\"#cite_note-forbes.com-20\">&#91;20&#93;</a></sup> Some examples of PV regulatory agencies in ROW are as follows. In Iraq, PV is regulated by the Iraqi Pharmacovigilance Center of the Iraqi Ministry of Health.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> \n</p>\n<h2><span id=\"Pharmacoenvironmentology.3B_.28Ecopharmacovigilance_.5BEPV.5D.29\"></span><span class=\"mw-headline\" id=\"Pharmacoenvironmentology;_(Ecopharmacovigilance_[EPV])\">Pharmacoenvironmentology; (Ecopharmacovigilance [EPV])</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=34\" title=\"Edit section: Pharmacoenvironmentology; (Ecopharmacovigilance [EPV])\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Despite attention from the FDA and regulatory agencies of the European Union, procedures for monitoring drug concentrations and adverse effects in the environment are lacking.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> Pharmaceuticals, their metabolites, and related substances may enter the environment after patient excretion, after direct release to waste streams during manufacturing or administration, or via terrestrial deposits (e.g., from waste sludges or leachates).<sup id=\"cite_ref-ncbi.nlm.nih.gov_34-0\" class=\"reference\"><a href=\"#cite_note-ncbi.nlm.nih.gov-34\">&#91;34&#93;</a></sup> A concept combining pharmacovigilance and environmental pharmacology, intended to focus attention on this area, was introduced first as <i>pharmacoenvironmentology</i> in 2006 by <a href=\"/wiki/Syed_Ziaur_Rahman\" title=\"Syed Ziaur Rahman\">Syed Ziaur Rahman</a> and later as <i>ecopharmacology</i> with further concurrent and later terms for the same concept (ecopharmacovigilance [EPV], environmental pharmacology, ecopharmacostewardship).<sup id=\"cite_ref-ncbi.nlm.nih.gov_34-1\" class=\"reference\"><a href=\"#cite_note-ncbi.nlm.nih.gov-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup><sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup>\n</p><p>The first of these routes to the environment, elimination through living organisms subsequent to pharmacotherapy, is suggested as the principal source of environmental contamination (apart from cases where norms for treatment of manufacturing and other wastes are violated), and EPV is intended to deal specifically with this impact of pharmacological agents on the environment.<sup id=\"cite_ref-ncbi.nlm.nih.gov_34-2\" class=\"reference\"><a href=\"#cite_note-ncbi.nlm.nih.gov-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup>\n</p><p>Activities of EPV have been suggested to include:\n</p>\n<ul><li>Increasing, generally, the availability of environmental data on medicinal products;</li>\n<li>Tracking emerging data on environmental exposure, effects and risks after product launch;</li>\n<li>Using Environmental Risk Management Plans (ERMPs) to manage risk throughout a drug's life cycle;</li>\n<li>Following risk identification, promoting further research and environmental monitoring, and</li>\n<li>In general, promoting a global perspective on EPV issues.<sup id=\"cite_ref-ncbi.nlm.nih.gov_34-3\" class=\"reference\"><a href=\"#cite_note-ncbi.nlm.nih.gov-34\">&#91;34&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"Related_to_medical_devices\">Related to medical devices</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=35\" title=\"Edit section: Related to medical devices\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>A <a href=\"/wiki/Medical_device\" title=\"Medical device\">medical device</a> is an instrument, apparatus, implant, <i>in vitro</i> reagent, or similar or related article that is used to diagnose, prevent, or treat disease or other conditions, and does not achieve its purposes through chemical action within or on the body (which would make it a <a href=\"/wiki/Drug\" title=\"Drug\">drug</a>).  Whereas medicinal products (also called pharmaceuticals) achieve their principal action by pharmacological, metabolic or immunological means, medical devices act by physical, mechanical, or thermal means.  Medical devices vary greatly in complexity and application.  Examples range from simple devices such as <a href=\"/wiki/Tongue_depressors\" class=\"mw-redirect\" title=\"Tongue depressors\">tongue depressors</a>, medical <a href=\"/wiki/Thermometers\" class=\"mw-redirect\" title=\"Thermometers\">thermometers</a>, and disposable gloves to advanced devices such as <a href=\"/wiki/Medical_robots\" class=\"mw-redirect\" title=\"Medical robots\">medical robots</a>, <a href=\"/wiki/Cardiac_pacemakers\" class=\"mw-redirect\" title=\"Cardiac pacemakers\">cardiac pacemakers</a>, and <a href=\"/wiki/Neuroprosthetics\" title=\"Neuroprosthetics\">neuroprosthetics</a>.\n</p><p>Given the inherent difference between medicinal products and medical products, the vigilance of medical devices is also different from that of medicinal products.  To reflect this difference, a classification system has been adopted in some countries to stratify the risk of failure with the different classes of devices.  The classes of devices typically run on a 1-3 or 1-4 scale, with Class 1 being the least likely to cause significant harm with device failure versus Classes 3 or 4 being the most likely to cause significant harm with device failure.  An example of a device in the \"low risk\" category would be contact lenses.  An example of a device in the \"high risk\" category would be cardiac pacemakers.\n</p><p>Medical device reporting (MDR), which is the reporting of adverse events with medical devices, is similar to that with medicinal products, although there are differences.  For instance, in the US user-facilities such as hospitals and nursing homes are legally required to report suspected medical device-related deaths to both FDA and the manufacturer, if known, and serious injuries to the manufacturer or to FDA, if the manufacturer is unknown.<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup>  This is in contrast to the voluntary reporting of AEs with medicinal products.\n</p>\n<h2><span class=\"mw-headline\" id=\"For_herbal_medicines\">For herbal medicines</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=36\" title=\"Edit section: For herbal medicines\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><div class=\"mw-collapsible\" style=\"width:95%; margin: 0.2em 0;\"><b>This section has multiple issues.</b> Please help <b><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve it</a></b> or discuss these issues on the <b><a href=\"/wiki/Talk:Pharmacovigilance\" title=\"Talk:Pharmacovigilance\">talk page</a></b>. <small><i>(<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove these template messages</a>)</i></small>\n<div class=\"mw-collapsible-content\" style=\"margin-top: 0.3em;\">\n      <table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>&#32;with: specific verifiable information, rather than vague statements. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(March 2014)</i></small></div></td></tr></tbody></table>\n    </div>\n</div><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>The safety of herbal medicines has become a major concern to both national health authorities and the general public.<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources#What_information_to_include\" title=\"Wikipedia:Citing sources\"><span title=\"A complete citation is needed (March 2014)\">full citation needed</span></a></i>&#93;</sup> The use of herbs as <a href=\"/wiki/Traditional_medicines\" class=\"mw-redirect\" title=\"Traditional medicines\">traditional medicines</a> continues to expand rapidly<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Vagueness\" title=\"Wikipedia:Vagueness\"><span title=\"This information is too vague. (March 2014)\">vague</span></a></i>&#93;</sup> across the world; many people<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Vagueness\" title=\"Wikipedia:Vagueness\"><span title=\"This information is too vague. (March 2014)\">vague</span></a></i>&#93;</sup> now take herbal medicines or <a href=\"/wiki/Herbal_products\" class=\"mw-redirect\" title=\"Herbal products\">herbal products</a> for their health care in different national health-care settings.<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Vagueness\" title=\"Wikipedia:Vagueness\"><span title=\"This information is too vague. (March 2014)\">vague</span></a></i>&#93;</sup><sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> However, mass media reports<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Avoid_weasel_words\" class=\"mw-redirect\" title=\"Wikipedia:Avoid weasel words\"><span title=\"The material near this tag possibly uses too vague attribution or weasel words. (March 2014)\">which?</span></a></i>&#93;</sup> of adverse events with herbal medicines can be incomplete and therefore misleading.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2014)\">citation needed</span></a></i>&#93;</sup> Moreover, it can be difficult to identify the causes of herbal medicine-associated adverse events since the amount of data on each event is generally less than for pharmaceuticals formally regulated as drugs (since the requirements for adverse event reporting are either non-existent or are less stringent for herbal supplements and medications).<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Industry_associations\">Industry associations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=37\" title=\"Edit section: Industry associations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><b>This section is empty.</b> <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(November 2013)</i></small></div></td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=38\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"div-col columns column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;\">\n<ul><li><a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">Adverse drug reaction</a></li>\n<li><a href=\"/wiki/Adverse_effect_(medicine)\" class=\"mw-redirect\" title=\"Adverse effect (medicine)\">Adverse effect (medicine)</a></li>\n<li><a href=\"/wiki/Boston_Collaborative_Drug_Surveillance_Program\" title=\"Boston Collaborative Drug Surveillance Program\">Boston Collaborative Drug Surveillance Program</a></li>\n<li><a href=\"/wiki/Consultant_pharmacist\" title=\"Consultant pharmacist\">Consultant pharmacist</a></li>\n<li><a href=\"/wiki/COSTART\" title=\"COSTART\">COSTART</a> \u2013 Coding Symbols for a Thesaurus of Adverse Reaction Terms</li>\n<li><a href=\"/wiki/DrugLogic\" title=\"DrugLogic\">DrugLogic</a></li>\n<li><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a></li>\n<li><a href=\"/wiki/EudraVigilance\" title=\"EudraVigilance\">EudraVigilance</a></li>\n<li><a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration (US FDA)</a></li>\n<li><a href=\"/wiki/International_Society_for_Pharmacoepidemiology\" title=\"International Society for Pharmacoepidemiology\">International Society for Pharmacoepidemiology</a></li>\n<li><a href=\"/wiki/International_Society_of_Pharmacovigilance\" title=\"International Society of Pharmacovigilance\">International Society of Pharmacovigilance</a></li>\n<li><a href=\"/wiki/List_of_withdrawn_drugs\" title=\"List of withdrawn drugs\">List of withdrawn drugs</a></li>\n<li><a href=\"/wiki/Society_of_Pharmacovigilance,_India\" title=\"Society of Pharmacovigilance, India\">Society of Pharmacovigilance, India</a> (SoPI)</li>\n<li><a href=\"/wiki/MedDRA\" title=\"MedDRA\">MedDRA</a> \u2013 Medical Dictionary for Regulatory Activities</li>\n<li><a href=\"/wiki/Medical_device\" title=\"Medical device\">Medical device</a></li>\n<li><a href=\"/wiki/MedWatch\" title=\"MedWatch\">MedWatch</a></li>\n<li><a href=\"/wiki/National_Drug_%26_Safety_League\" title=\"National Drug &amp; Safety League\">National Drug &amp; Safety League</a></li>\n<li><a href=\"/wiki/Public_health\" title=\"Public health\">Public health</a></li>\n<li><a href=\"/wiki/Pharmacoepidemiology\" title=\"Pharmacoepidemiology\">Pharmacoepidemiology</a></li>\n<li><a href=\"/wiki/Pharmacotherapy\" title=\"Pharmacotherapy\">Pharmacotherapy</a></li>\n<li><a href=\"/wiki/Pharmacogenetics\" title=\"Pharmacogenetics\">Pharmacogenetics</a></li>\n<li><a href=\"/wiki/Pharmacogenomics\" title=\"Pharmacogenomics\">Pharmacogenomics</a></li>\n<li><a href=\"/wiki/Pharmaceuticals_and_personal_care_products_in_the_environment\" class=\"mw-redirect\" title=\"Pharmaceuticals and personal care products in the environment\">Pharmaceuticals and personal care products in the environment</a></li>\n<li><a href=\"/wiki/Proportional_reporting_ratio\" title=\"Proportional reporting ratio\">Proportional reporting ratio</a></li>\n<li><a href=\"/wiki/Uppsala_Monitoring_Centre\" title=\"Uppsala Monitoring Centre\">Uppsala Monitoring Centre</a></li>\n<li><a href=\"/wiki/WHOART\" title=\"WHOART\">WHOART</a></li>\n<li><a href=\"/wiki/Yellow_Card_Scheme\" title=\"Yellow Card Scheme\">Yellow Card Scheme</a> (UK)</li>\n<li><a href=\"/wiki/Black_triangle_(pharmacovigilance)\" title=\"Black triangle (pharmacovigilance)\">Black triangle (pharmacovigilance)</a></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=39\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\">Source: The Importance of Pharmacovigilance, WHO 2002</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ec.europa.eu/health/files/eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf\">\"DIRECTIVE 2010/84/EU, Article 101\"</a> <span style=\"font-size:85%;\">(PDF)</span>. ec.europa.eu<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-10-26</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=DIRECTIVE+2010%2F84%2FEU%2C+Article+101&amp;rft.pub=ec.europa.eu&amp;rft_id=http%3A%2F%2Fec.europa.eu%2Fhealth%2Ffiles%2Feudralex%2Fvol-1%2Fdir_2010_84%2Fdir_2010_84_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who-umc.org/media/2680/who-technical-report-498.pdf\">\"International Drug Monitoring&#160;: The Role of National Centers\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Who-umc.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=International+Drug+Monitoring+%3A+The+Role+of+National+Centers&amp;rft.pub=Who-umc.org&amp;rft_id=https%3A%2F%2Fwww.who-umc.org%2Fmedia%2F2680%2Fwho-technical-report-498.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://sjpharmaco.com/Preparing%20for%20a%20Pharmacovigilance%20Safety%20Inspection.pdf\">\"Preparing for a Safety Inspection\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Steve Jolley. 2011<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-01-04</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Preparing+for+a+Safety+Inspection&amp;rft.pub=Steve+Jolley&amp;rft.date=2011&amp;rft_id=http%3A%2F%2Fsjpharmaco.com%2FPreparing%2520for%2520a%2520Pharmacovigilance%2520Safety%2520Inspection.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pharmacovigilance_p_V-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pharmacovigilance_p_V_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pharmacovigilance_p_V_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><i>Current Challenges in Pharmacovigilance: Pragmatic Approaches</i> (Report of CIOMS Working Group V), 2001 Geneva.</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.acrin.org/Portals/0/Administration/Regulatory/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf\">\"Common Terminology Criteria for Adverse Events (CTCAE)&#160;: Version 4.0\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Acrin.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Common+Terminology+Criteria+for+Adverse+Events+%28CTCAE%29+%3A+Version+4.0&amp;rft.pub=Acrin.org&amp;rft_id=http%3A%2F%2Fwww.acrin.org%2FPortals%2F0%2FAdministration%2FRegulatory%2FCTCAE_4.02_2009-09-15_QuickReference_5x7.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. <i>Drug Information Journal</i>, 2008, 42:409-419.</span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.ich.org/cache/compo/475-272-1.html\">[1]</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20101110015452/http://www.ich.org/cache/compo/475-272-1.html\">Archived</a> November 10, 2010, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://estri.ich.org/new-icsr/index.htm\">[2]</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20100823124028/http://estri.ich.org/new-icsr/index.htm\">Archived</a> August 23, 2010, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who-umc.org/DynPage.aspx?id=13140&amp;mn=1514\">\"Uppsala Monitoring Centre\"</a>. who-umc.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Uppsala+Monitoring+Centre&amp;rft.pub=who-umc.org&amp;rft_id=http%3A%2F%2Fwww.who-umc.org%2FDynPage.aspx%3Fid%3D13140%26mn%3D1514&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><i>Pharmacovigilance</i>. Mann RD, Andrews EB, eds. John Wiley &amp; Sons Ltd, Chichester, 2002.\nspontaneous reports are very useful.</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ireminder.com/products/medtrigger\">\"(REMS)Risk Evaluation Mitigation Strategies and ETASU programs\"</a>. Ireminder.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=%28REMS%29Risk+Evaluation+Mitigation+Strategies+and+ETASU+programs&amp;rft.pub=Ireminder.com&amp;rft_id=http%3A%2F%2Fireminder.com%2Fproducts%2Fmedtrigger&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Strom, Brian (2006). <i>Textbook of Pharmacoepidemiology</i>. West Sussex, England: John Wiley and Sons. p.&#160;3. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-470-02925-1\" title=\"Special:BookSources/978-0-470-02925-1\">978-0-470-02925-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Textbook+of+Pharmacoepidemiology&amp;rft.place=West+Sussex%2C+England&amp;rft.pages=3&amp;rft.pub=John+Wiley+and+Sons&amp;rft.date=2006&amp;rft.isbn=978-0-470-02925-1&amp;rft.aulast=Strom&amp;rft.aufirst=Brian&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who-umc.org/global-pharmacovigilance/who-programme\">\"UMC - WHO Programme\"</a>. <i>www.who-umc.org</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.who-umc.org&amp;rft.atitle=UMC+-+WHO+Programme&amp;rft_id=https%3A%2F%2Fwww.who-umc.org%2Fglobal-pharmacovigilance%2Fwho-programme&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who-umc.org/global-pharmacovigilance/who-programme/being-a-member/\">\"UMC - Being a member\"</a>. <i>www.who-umc.org</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.who-umc.org&amp;rft.atitle=UMC+-+Being+a+member&amp;rft_id=https%3A%2F%2Fwww.who-umc.org%2Fglobal-pharmacovigilance%2Fwho-programme%2Fbeing-a-member%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org/about/organisation-of-ich.html\">\"Organisation\"</a>. ICH<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Organisation&amp;rft.pub=ICH&amp;rft_id=http%3A%2F%2Fwww.ich.org%2Fabout%2Forganisation-of-ich.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150227142309/http://www.ich.org/about/organisation-of-ich/steering.html\">\"Steering Committee\"</a>. ICH. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org/about/organisation-of-ich/steering.html\">the original</a> on 2015-02-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Steering+Committee&amp;rft.pub=ICH&amp;rft_id=http%3A%2F%2Fwww.ich.org%2Fabout%2Forganisation-of-ich%2Fsteering.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.isoponline.org/\">\"ISoP&#160;: International Society of Pharmacovigilance - Home\"</a>. Isoponline.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ISoP+%3A+International+Society+of+Pharmacovigilance+-+Home&amp;rft.pub=Isoponline.org&amp;rft_id=http%3A%2F%2Fwww.isoponline.org%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/medicinedocs/en/d/Js4893e/3.html\">\"The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products: Chapter 2 - A Short History of Involvement in Drug Safety Monitoring by WHO\"</a>. Apps.who.int. 2015-02-10<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Importance+of+Pharmacovigilance+-+Safety+Monitoring+of+Medicinal+Products%3A+Chapter+2+-+A+Short+History+of+Involvement+in+Drug+Safety+Monitoring+by+WHO&amp;rft.pub=Apps.who.int&amp;rft.date=2015-02-10&amp;rft_id=http%3A%2F%2Fapps.who.int%2Fmedicinedocs%2Fen%2Fd%2FJs4893e%2F3.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-forbes.com-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-forbes.com_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-forbes.com_20-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.forbes.com/sites/matthewherper/2012/07/12/the-global-drug-market-will-swell-to-1-2-trillion-while-big-pharma-treads-water/\">\"Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market\"</a>. Forbes. 2012-12-07<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Why+Big+Pharma+Won%27t+Get+Its+Piece+Of+The+%241.2+Trillion+Global+Drug+Market&amp;rft.pub=Forbes&amp;rft.date=2012-12-07&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F07%2F12%2Fthe-global-drug-market-will-swell-to-1-2-trillion-while-big-pharma-treads-water%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.clinicalleader.com/doc/chinas-pharmacovigilance-system-the-hunger-0001\">\"China's Pharmacovigilance System: The Hunger For Safety Insights\"</a>. Clinicalleader.com. 2011-12-07<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=China%27s+Pharmacovigilance+System%3A+The+Hunger+For+Safety+Insights&amp;rft.pub=Clinicalleader.com&amp;rft.date=2011-12-07&amp;rft_id=http%3A%2F%2Fwww.clinicalleader.com%2Fdoc%2Fchinas-pharmacovigilance-system-the-hunger-0001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.biopharminternational.com/biopharm/article/articleDetail.jsp?id=810540&amp;sk=&amp;date=&amp;pageID=3\">\"Navigating Emerging Markets \u2014 Latin America\"</a>. Biopharminternational.com. 2013-04-01<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Navigating+Emerging+Markets+%E2%80%94+Latin+America&amp;rft.pub=Biopharminternational.com&amp;rft.date=2013-04-01&amp;rft_id=http%3A%2F%2Fwww.biopharminternational.com%2Fbiopharm%2Farticle%2FarticleDetail.jsp%3Fid%3D810540%26sk%3D%26date%3D%26pageID%3D3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-vigilance2012-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-vigilance2012_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-vigilance2012_23-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hoffmann E, Fouretier A, Vergne C,  et al. (2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/article/10.1007/BF03262389\">\"Pharmacovigilance Regulatory Requirements in Latin America\"</a>. <i>Pharm Med</i>. <b>26</b> (3): 153\u2013164. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/bf03262389\">10.1007/bf03262389</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharm+Med&amp;rft.atitle=Pharmacovigilance+Regulatory+Requirements+in+Latin+America&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=153-164&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1007%2Fbf03262389&amp;rft.aulast=Hoffmann&amp;rft.aufirst=E&amp;rft.au=Fouretier%2C+A&amp;rft.au=Vergne%2C+C&amp;rft_id=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2FBF03262389&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.paho.org/hq/index.php?option=com_content&amp;view=category&amp;layout=blog&amp;id=1156&amp;Itemid=513\">\"Pan American Network for Drug Regulatory Harmonization\"</a>. Paho.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pan+American+Network+for+Drug+Regulatory+Harmonization&amp;rft.pub=Paho.org&amp;rft_id=http%3A%2F%2Fwww.paho.org%2Fhq%2Findex.php%3Foption%3Dcom_content%26view%3Dcategory%26layout%3Dblog%26id%3D1156%26Itemid%3D513&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ipc.gov.in\">\"Indian Pharmacopoeia Commission, Ministry of Health &amp; Family Welfare, Government of India\"</a>. Ipc.gov.in<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Indian+Pharmacopoeia+Commission%2C+Ministry+of+Health+%26+Family+Welfare%2C+Government+of+India&amp;rft.pub=Ipc.gov.in&amp;rft_id=http%3A%2F%2Fwww.ipc.gov.in&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cdsco.nic.in\">\"Central Drugs Standard Control Organization\"</a>. Cdsco.nic.in<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Central+Drugs+Standard+Control+Organization&amp;rft.pub=Cdsco.nic.in&amp;rft_id=http%3A%2F%2Fwww.cdsco.nic.in&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000456.jsp&amp;mid=WC0b01ac05801ae8fb\">\"Safety monitoring of medicines\"</a> European Medicines Agency</span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://heads.medagencies.org/\">\"Heads of Medicines Agencies: Home\"</a>. Heads.medagencies.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Heads+of+Medicines+Agencies%3A+Home&amp;rft.pub=Heads.medagencies.org&amp;rft_id=http%3A%2F%2Fheads.medagencies.org%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">GUERRIAUD, Mathieu (2016-02-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bnds.fr/revue/rgdm/panorama-de-droit-pharmaceutique-2015/pharmacovigilance-europeenne-un-systeme-aux-multiples-visages-6101.html\">\"Pharmacovigilance europ\u00e9enne, un syst\u00e8me aux multiples visages\"</a>. <i>BNDS</i> (in French)<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-07-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BNDS&amp;rft.atitle=Pharmacovigilance+europ%C3%A9enne%2C+un+syst%C3%A8me+aux+multiples+visages&amp;rft.date=2016-02-01&amp;rft.aulast=GUERRIAUD&amp;rft.aufirst=Mathieu&amp;rft_id=http%3A%2F%2Fwww.bnds.fr%2Frevue%2Frgdm%2Fpanorama-de-droit-pharmaceutique-2015%2Fpharmacovigilance-europeenne-un-systeme-aux-multiples-visages-6101.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150227141047/http://se-fc.org/gestor/farmacovigilancia/generalidades.html\">\"Generalidades\"</a>. Se-fc.org. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://se-fc.org/gestor/farmacovigilancia/generalidades.html\">the original</a> on 2015-02-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Generalidades&amp;rft.pub=Se-fc.org&amp;rft_id=http%3A%2F%2Fse-fc.org%2Fgestor%2Ffarmacovigilancia%2Fgeneralidades.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.swissmedic.ch/bewilligungen/00155/00242/00327/00345/index.html?lang=en\">\"GCP and Pharmacovigilance Inspections - Swissmedic\"</a>. Swissmedic.ch<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GCP+and+Pharmacovigilance+Inspections+-+Swissmedic&amp;rft.pub=Swissmedic.ch&amp;rft_id=https%3A%2F%2Fwww.swissmedic.ch%2Fbewilligungen%2F00155%2F00242%2F00327%2F00345%2Findex.html%3Flang%3Den&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pv.pharmacyboardkenya.org\">\"Pharmacovigilance Electronic Reporting System - Kenya\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmacovigilance+Electronic+Reporting+System+-+Kenya&amp;rft_id=http%3A%2F%2Fwww.pv.pharmacyboardkenya.org&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://pharmacology.uonbi.ac.ke//uon_degrees_details/751\">\"Master of Pharmacy in Pharmacoepidemiology &amp; Pharmacovigilance\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">28 Jun</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Master+of+Pharmacy+in+Pharmacoepidemiology+%26+Pharmacovigilance&amp;rft_id=http%3A%2F%2Fpharmacology.uonbi.ac.ke%2F%2Fuon_degrees_details%2F751&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ncbi.nlm.nih.gov-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ncbi.nlm.nih.gov_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ncbi.nlm.nih.gov_34-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ncbi.nlm.nih.gov_34-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ncbi.nlm.nih.gov_34-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Holm, G; Snape, JR; Murray-Smith, R; Talbot, J; Taylor, D; S\u00f6rme, P (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3691479\">\"Implementing Ecopharmacovigilance in Practice: Challenges and Potential Opportunities\"</a>. <i>Drug Saf</i>. <b>36</b>: 533\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s40264-013-0049-3\">10.1007/s40264-013-0049-3</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3691479\">3691479</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23620169\">23620169</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Saf&amp;rft.atitle=Implementing+Ecopharmacovigilance+in+Practice%3A+Challenges+and+Potential+Opportunities&amp;rft.volume=36&amp;rft.pages=533-46&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691479&amp;rft_id=info%3Apmid%2F23620169&amp;rft_id=info%3Adoi%2F10.1007%2Fs40264-013-0049-3&amp;rft.aulast=Holm&amp;rft.aufirst=G&amp;rft.au=Snape%2C+JR&amp;rft.au=Murray-Smith%2C+R&amp;rft.au=Talbot%2C+J&amp;rft.au=Taylor%2C+D&amp;rft.au=S%C3%B6rme%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691479&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rahman, SZ; Khan, RA (Dec 2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ijp-online.com/text.asp?2006/38/4/229/27017\">\"Environmental pharmacology: A new discipline\"</a>. <i>Indian J Pharmacol</i>. <b>38</b> (4): 229\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4103/0253-7613.27017\">10.4103/0253-7613.27017</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Indian+J+Pharmacol.&amp;rft.atitle=Environmental+pharmacology%3A+A+new+discipline&amp;rft.volume=38&amp;rft.issue=4&amp;rft.pages=229-30&amp;rft.date=2006-12&amp;rft_id=info%3Adoi%2F10.4103%2F0253-7613.27017&amp;rft.aulast=Rahman&amp;rft.aufirst=SZ&amp;rft.au=Khan%2C+RA&amp;rft_id=http%3A%2F%2Fwww.ijp-online.com%2Ftext.asp%3F2006%2F38%2F4%2F229%2F27017&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Rahman, SZ; Khan RA; Gupta V; Misbah Uddin (2008). \"Chapter 2: Pharmacoenvironmentology \u2013 Ahead of Pharmacovigilance\".  In Rahman SZ, Shahid M &amp; Gupta A. <i>An Introduction to Environmental Pharmacology</i> (1st ed.). Aligarh: Ibn Sina Academy. pp.&#160;35\u201352. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-81-906070-4-9\" title=\"Special:BookSources/978-81-906070-4-9\">978-81-906070-4-9</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+2%3A+Pharmacoenvironmentology+%E2%80%93+Ahead+of+Pharmacovigilance&amp;rft.btitle=An+Introduction+to+Environmental+Pharmacology&amp;rft.place=Aligarh&amp;rft.pages=35-52&amp;rft.edition=1st&amp;rft.pub=Ibn+Sina+Academy&amp;rft.date=2008&amp;rft.isbn=978-81-906070-4-9&amp;rft.aulast=Rahman&amp;rft.aufirst=SZ&amp;rft.au=Khan+RA&amp;rft.au=Gupta+V&amp;rft.au=Misbah+Uddin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ruhoy, IS; Daughton, CG (2008). \"Beyond the medicine cabinet: An analysis of where and why medications accumulate\". <i>Environment International</i>. <b>34</b> (8): 1157\u20131169. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.envint.2008.05.002\">10.1016/j.envint.2008.05.002</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Environment+International&amp;rft.atitle=Beyond+the+medicine+cabinet%3A+An+analysis+of+where+and+why+medications+accumulate&amp;rft.volume=34&amp;rft.issue=8&amp;rft.pages=1157-1169&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.envint.2008.05.002&amp;rft.aulast=Ruhoy&amp;rft.aufirst=IS&amp;rft.au=Daughton%2C+CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rahman, SZ; Khan, RA; Gupta, V; Uddin, Misbah (July 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ehjournal.net/content/6/1/20\">\"Pharmacoenvironmentology \u2013 A Component of Pharmacovigilance\"</a>. <i>Environmental Health</i>. <b>6</b> (20). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/1476-069X-6-20\">10.1186/1476-069X-6-20</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1947975\">1947975</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17650313\">17650313</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Environmental+Health&amp;rft.atitle=Pharmacoenvironmentology+%E2%80%93+A+Component+of+Pharmacovigilance&amp;rft.volume=6&amp;rft.issue=20&amp;rft.date=2007-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1947975&amp;rft_id=info%3Apmid%2F17650313&amp;rft_id=info%3Adoi%2F10.1186%2F1476-069X-6-20&amp;rft.aulast=Rahman&amp;rft.aufirst=SZ&amp;rft.au=Khan%2C+RA&amp;rft.au=Gupta%2C+V&amp;rft.au=Uddin%2C+Misbah&amp;rft_id=http%3A%2F%2Fwww.ehjournal.net%2Fcontent%2F6%2F1%2F20&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/Safety/MedWatch/HowToReport/ucm085568.htm\">\"Reporting By Health Professionals\"</a>. Fda.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-02-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Reporting+By+Health+Professionals&amp;rft.pub=Fda.gov&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FSafety%2FMedWatch%2FHowToReport%2Fucm085568.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\">WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems, World Health Organization, Geneva, 2004</span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\">S Z Rahman &amp; K C Singhal, Problems in pharmacovigilance of medicinal products of herbal origin and means to minimize them, Uppsala Reports, WHO Collaborating Center for ADR monitoring, Uppsala Monitoring Centre, Sweden, Issue 17 January 2002: 1-4 (Supplement)</span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacovigilance&amp;action=edit&amp;section=40\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/40px-Wiktionary-logo-en-v2.svg.png\" width=\"40\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/60px-Wiktionary-logo-en-v2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/80px-Wiktionary-logo-en-v2.svg.png 2x\" data-file-width=\"512\" data-file-height=\"512\" /></td>\n<td class=\"mbox-text plainlist\">Look up <i><b><a href=\"https://en.wiktionary.org/wiki/Special:Search/pharmacovigilance\" class=\"extiw\" title=\"wiktionary:Special:Search/pharmacovigilance\">pharmacovigilance</a></b></i> in Wiktionary, the free dictionary.</td></tr></tbody></table>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060924192651/http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&amp;nodeId=368\">Current Problems in Pharmacovigilance</a></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126834.pdf\">\"Guidance for Industry. Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">Food and Drug Administration</a>. March 2005<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-07-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guidance+for+Industry.+Good+Pharmacovigilance+Practices+and+Pharmacoepidemiologic+Assessment&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2005-03&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FRegulatoryInformation%2FGuidances%2FUCM126834.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacovigilance\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://medsfacts.com\">Public-access adverse event reference</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://ec.europa.eu/health/documents/eudralex/vol-9/index_en.htm\">Volume 9 of \"The rules governing medicinal products in the European Union\" contains Pharmacovigilance guidelines for medicinal products for both human and veterinary use.</a></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Public_health\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Public_health\" title=\"Template:Public health\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Public_health\" title=\"Template talk:Public health\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Public_health&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Public_health\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Public_health\" title=\"Public health\">Public health</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">General</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Auxology\" title=\"Auxology\">Auxology</a></li>\n<li><a href=\"/wiki/Biological_hazard\" title=\"Biological hazard\">Biological hazard</a></li>\n<li><a href=\"/wiki/Chief_Medical_Officer\" title=\"Chief Medical Officer\">Chief Medical Officer</a></li>\n<li><a href=\"/wiki/Cultural_competence_in_health_care\" class=\"mw-redirect\" title=\"Cultural competence in health care\">Cultural competence</a></li>\n<li><a href=\"/wiki/Deviance_(sociology)\" title=\"Deviance (sociology)\">Deviance</a></li>\n<li><a href=\"/wiki/Environmental_health\" title=\"Environmental health\">Environmental health</a></li>\n<li><a href=\"/wiki/Euthenics\" title=\"Euthenics\">Euthenics</a></li>\n<li><a href=\"/wiki/Public_health_genomics\" title=\"Public health genomics\">Genomics</a></li>\n<li><a href=\"/wiki/Globalization_and_disease\" title=\"Globalization and disease\">Globalization and disease</a></li>\n<li><a href=\"/wiki/Health_economics\" title=\"Health economics\">Health economics</a></li>\n<li><a href=\"/wiki/Health_literacy\" title=\"Health literacy\">Health literacy</a></li>\n<li><a href=\"/wiki/Health_policy\" title=\"Health policy\">Health policy</a>\n<ul><li><a href=\"/wiki/Health_system\" title=\"Health system\">Health system</a></li>\n<li><a href=\"/wiki/Health_care_reform\" title=\"Health care reform\">Health care reform</a></li>\n<li><a href=\"/wiki/Public_health_law\" title=\"Public health law\">Public health law</a></li></ul></li>\n<li><a href=\"/wiki/Maternal_health\" title=\"Maternal health\">Maternal health</a></li>\n<li><a href=\"/wiki/Medical_anthropology\" title=\"Medical anthropology\">Medical anthropology</a></li>\n<li><a href=\"/wiki/Medical_sociology\" title=\"Medical sociology\">Medical sociology</a></li>\n<li><a href=\"/wiki/Mental_health\" title=\"Mental health\">Mental health</a></li>\n<li><a href=\"/wiki/Pharmaceutical_policy\" title=\"Pharmaceutical policy\">Pharmaceutical policy</a></li>\n<li><a href=\"/wiki/Public_health_intervention\" title=\"Public health intervention\">Public health intervention</a></li>\n<li><a href=\"/wiki/Public_health_laboratory\" title=\"Public health laboratory\">Public health laboratory</a></li>\n<li><a href=\"/wiki/Reproductive_health\" title=\"Reproductive health\">Reproductive health</a></li>\n<li><a href=\"/wiki/Social_psychology\" title=\"Social psychology\">Social psychology</a></li>\n<li><a href=\"/wiki/Sociology_of_health_and_illness\" title=\"Sociology of health and illness\">Sociology of health and illness</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Preventive_healthcare\" title=\"Preventive healthcare\">Preventive healthcare</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Behavior_change_(public_health)\" title=\"Behavior change (public health)\">Behavior change</a>\n<ul><li><a href=\"/wiki/Behavioural_change_theories\" title=\"Behavioural change theories\">Theories</a></li></ul></li>\n<li><a href=\"/wiki/Family_planning\" title=\"Family planning\">Family planning</a></li>\n<li><a href=\"/wiki/Health_promotion\" title=\"Health promotion\">Health promotion</a></li>\n<li><a href=\"/wiki/Human_nutrition\" title=\"Human nutrition\">Human nutrition</a></li>\n<li><a href=\"/wiki/Preventive_nutrition\" title=\"Preventive nutrition\">Preventive nutrition</a></li>\n<li><a href=\"/wiki/Hygiene\" title=\"Hygiene\">Hygiene</a>\n<ul><li><a href=\"/wiki/Food_safety\" title=\"Food safety\">Food safety</a></li>\n<li><a href=\"/wiki/Hand_washing\" title=\"Hand washing\">Hand washing</a></li>\n<li><a href=\"/wiki/Infection_control\" title=\"Infection control\">Infection control</a></li>\n<li><a href=\"/wiki/Oral_hygiene\" title=\"Oral hygiene\">Oral hygiene</a></li></ul></li>\n<li><a href=\"/wiki/Occupational_safety_and_health\" title=\"Occupational safety and health\">Occupational safety and health</a>\n<ul><li><a href=\"/wiki/Human_factors_and_ergonomics\" title=\"Human factors and ergonomics\">Human factors and ergonomics</a></li>\n<li><a href=\"/wiki/Occupational_hygiene\" title=\"Occupational hygiene\">Hygiene</a></li>\n<li><a href=\"/wiki/Injury_prevention\" title=\"Injury prevention\">Injury prevention</a></li>\n<li><a href=\"/wiki/Occupational_medicine\" title=\"Occupational medicine\">Medicine</a></li>\n<li><a href=\"/wiki/Occupational_health_nursing\" title=\"Occupational health nursing\">Nursing</a></li></ul></li>\n<li><a href=\"/wiki/Patient_safety\" title=\"Patient safety\">Patient safety</a>\n<ul><li><a href=\"/wiki/Patient_safety_organization\" title=\"Patient safety organization\">Organization</a></li></ul></li>\n<li><a class=\"mw-selflink selflink\">Pharmacovigilance</a></li>\n<li><a href=\"/wiki/Safe_sex\" title=\"Safe sex\">Safe sex</a></li>\n<li><a href=\"/wiki/Sanitation\" title=\"Sanitation\">Sanitation</a>\n<ul><li><a href=\"/wiki/Emergency_sanitation\" title=\"Emergency sanitation\">Emergency</a></li>\n<li><a href=\"/wiki/Fecal%E2%80%93oral_route\" title=\"Fecal\u2013oral route\">Fecal\u2013oral transmission</a></li>\n<li><a href=\"/wiki/Open_defecation\" title=\"Open defecation\">Open defecation</a></li>\n<li><a href=\"/wiki/Sanitary_sewer\" title=\"Sanitary sewer\">Sanitary sewer</a></li>\n<li><a href=\"/wiki/Waterborne_diseases\" title=\"Waterborne diseases\">Waterborne diseases</a></li></ul></li>\n<li><a href=\"/wiki/Smoking_cessation\" title=\"Smoking cessation\">Smoking cessation</a></li>\n<li><a href=\"/wiki/Vaccination\" title=\"Vaccination\">Vaccination</a></li>\n<li><a href=\"/wiki/Vector_control\" title=\"Vector control\">Vector control</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Population_health\" title=\"Population health\">Population health</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Biostatistics\" title=\"Biostatistics\">Biostatistics</a></li>\n<li><a href=\"/wiki/Child_mortality\" title=\"Child mortality\">Child mortality</a></li>\n<li><a href=\"/wiki/Community_health\" title=\"Community health\">Community health</a></li>\n<li><a href=\"/wiki/Epidemiology\" title=\"Epidemiology\">Epidemiology</a></li>\n<li><a href=\"/wiki/Global_health\" title=\"Global health\">Global health</a></li>\n<li><a href=\"/wiki/Health_impact_assessment\" title=\"Health impact assessment\">Health impact assessment</a></li>\n<li><a href=\"/wiki/Health_system\" title=\"Health system\">Health system</a></li>\n<li><a href=\"/wiki/Infant_mortality\" title=\"Infant mortality\">Infant mortality</a></li>\n<li><a href=\"/wiki/List_of_open-source_health_software\" title=\"List of open-source health software\">Open-source healthcare software</a></li>\n<li><a href=\"/wiki/Public_health_informatics\" title=\"Public health informatics\">Public health informatics</a></li>\n<li><a href=\"/wiki/Social_determinants_of_health\" title=\"Social determinants of health\">Social determinants of health</a>\n<ul><li><a href=\"/wiki/Health_equity\" title=\"Health equity\">Health equity</a></li>\n<li><a href=\"/wiki/Race_and_health\" title=\"Race and health\">Race and health</a></li></ul></li>\n<li><a href=\"/wiki/Social_medicine\" title=\"Social medicine\">Social medicine</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Biological and<br />epidemiological statistics</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Case%E2%80%93control_study\" title=\"Case\u2013control study\">Case\u2013control study</a></li>\n<li><a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">Randomized controlled trial</a></li>\n<li><a href=\"/wiki/Relative_risk\" class=\"mw-redirect\" title=\"Relative risk\">Relative risk</a></li>\n<li><a href=\"/wiki/Statistical_hypothesis_testing\" title=\"Statistical hypothesis testing\">Statistical hypothesis testing</a>\n<ul><li><a href=\"/wiki/Analysis_of_variance\" title=\"Analysis of variance\">Analysis of variance (ANOVA)</a></li>\n<li><a href=\"/wiki/Regression_analysis\" title=\"Regression analysis\">Regression analysis</a></li>\n<li><a href=\"/wiki/ROC_curve\" class=\"mw-redirect\" title=\"ROC curve\">ROC curve</a></li>\n<li><a href=\"/wiki/Student%27s_t-test\" title=\"Student&#39;s t-test\">Student's <i>t</i>-test</a></li>\n<li><a href=\"/wiki/Z-test\" title=\"Z-test\"><i>Z</i>-test</a></li></ul></li>\n<li><a href=\"/wiki/List_of_statistical_packages\" title=\"List of statistical packages\">Statistical software</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Infectious and epidemic<br />disease prevention</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Asymptomatic_carrier\" title=\"Asymptomatic carrier\">Asymptomatic carrier</a></li>\n<li><a href=\"/wiki/Epidemic\" title=\"Epidemic\">Epidemics</a>\n<ul><li><a href=\"/wiki/List_of_epidemics\" title=\"List of epidemics\">List</a></li></ul></li>\n<li><a href=\"/wiki/Notifiable_disease\" title=\"Notifiable disease\">Notifiable diseases</a>\n<ul><li><a href=\"/wiki/List_of_notifiable_diseases\" title=\"List of notifiable diseases\">List</a></li></ul></li>\n<li><a href=\"/wiki/Public_health_surveillance\" title=\"Public health surveillance\">Public health surveillance</a>\n<ul><li><a href=\"/wiki/Disease_surveillance\" title=\"Disease surveillance\">Disease surveillance</a></li></ul></li>\n<li><a href=\"/wiki/Quarantine\" title=\"Quarantine\">Quarantine</a></li>\n<li><a href=\"/wiki/Sexually_transmitted_infection\" title=\"Sexually transmitted infection\">Sexually transmitted infection</a></li>\n<li><a href=\"/wiki/Tropical_disease\" title=\"Tropical disease\">Tropical disease</a></li>\n<li><a href=\"/wiki/Vaccine_trial\" title=\"Vaccine trial\">Vaccine trial</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Food hygiene and<br />safety management</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li>Food\n<ul><li><a href=\"/wiki/Food_additive\" title=\"Food additive\">Additive</a></li>\n<li><a href=\"/wiki/Food_chemistry\" title=\"Food chemistry\">Chemistry</a></li>\n<li><a href=\"/wiki/Food_engineering\" title=\"Food engineering\">Engineering</a></li>\n<li><a href=\"/wiki/Food_microbiology\" title=\"Food microbiology\">Microbiology</a></li>\n<li><a href=\"/wiki/Food_processing\" title=\"Food processing\">Processing</a></li>\n<li><a href=\"/wiki/Food_safety\" title=\"Food safety\">Safety</a></li>\n<li><a href=\"/wiki/Category:Food_safety_scandals\" title=\"Category:Food safety scandals\">Safety scandals</a></li></ul></li>\n<li><a href=\"/wiki/Genetically_modified_food\" title=\"Genetically modified food\">Genetically modified food</a></li>\n<li><a href=\"/wiki/Good_agricultural_practice\" title=\"Good agricultural practice\">Good agricultural practice</a></li>\n<li><a href=\"/wiki/Good_manufacturing_practice\" title=\"Good manufacturing practice\">Good manufacturing practice</a>\n<ul><li><a href=\"/wiki/HACCP\" class=\"mw-redirect\" title=\"HACCP\">HACCP</a></li>\n<li><a href=\"/wiki/ISO_22000\" title=\"ISO 22000\">ISO 22000</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Health behavioral<br />sciences</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Diffusion_of_innovations\" title=\"Diffusion of innovations\">Diffusion of innovations</a></li>\n<li><a href=\"/wiki/Health_belief_model\" title=\"Health belief model\">Health belief model</a></li>\n<li><a href=\"/wiki/Health_communication\" title=\"Health communication\">Health communication</a></li>\n<li><a href=\"/wiki/Health_psychology\" title=\"Health psychology\">Health psychology</a></li>\n<li><a href=\"/wiki/Positive_deviance\" title=\"Positive deviance\">Positive deviance</a></li>\n<li><a href=\"/wiki/PRECEDE-PROCEED_model\" class=\"mw-redirect\" title=\"PRECEDE-PROCEED model\">PRECEDE-PROCEED model</a></li>\n<li><a href=\"/wiki/Social_cognitive_theory\" title=\"Social cognitive theory\">Social cognitive theory</a></li>\n<li><a href=\"/wiki/Social_norms_approach\" title=\"Social norms approach\">Social norms approach</a></li>\n<li><a href=\"/wiki/Theory_of_planned_behavior\" title=\"Theory of planned behavior\">Theory of planned behavior</a></li>\n<li><a href=\"/wiki/Transtheoretical_model\" title=\"Transtheoretical model\">Transtheoretical model</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Organizations,<br />education<br />and history</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Organizations</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li>Europe\n<ul><li><a href=\"/wiki/European_Centre_for_Disease_Prevention_and_Control\" title=\"European Centre for Disease Prevention and Control\">Centre for Disease Prevention and Control</a></li>\n<li><a href=\"/wiki/European_Parliament_Committee_on_the_Environment,_Public_Health_and_Food_Safety\" title=\"European Parliament Committee on the Environment, Public Health and Food Safety\">Committee on the Environment, Public Health and Food Safety</a></li></ul></li>\n<li>India\n<ul><li><a href=\"/wiki/Ministry_of_Health_and_Family_Welfare\" title=\"Ministry of Health and Family Welfare\">Ministry of Health and Family Welfare</a></li></ul></li>\n<li>U.S.\n<ul><li><a href=\"/wiki/Centers_for_Disease_Control_and_Prevention\" title=\"Centers for Disease Control and Prevention\">Centers for Disease Control and Prevention</a></li>\n<li><a href=\"/wiki/Category:City_and_county_health_departments_in_the_United_States\" title=\"Category:City and county health departments in the United States\">City and county health departments</a></li>\n<li><a href=\"/wiki/Council_on_Education_for_Public_Health\" title=\"Council on Education for Public Health\">Council on Education for Public Health</a></li>\n<li><a href=\"/wiki/United_States_Public_Health_Service\" title=\"United States Public Health Service\">Public Health Service</a></li></ul></li>\n<li><a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a></li>\n<li><a href=\"/wiki/World_Toilet_Organization\" title=\"World Toilet Organization\">World Toilet Organization</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Education</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Health_education\" title=\"Health education\">Health education</a></li>\n<li>Higher education\n<ul><li><a href=\"/wiki/Bachelor_of_Science_in_Public_Health\" title=\"Bachelor of Science in Public Health\">Bachelor of Science in Public Health</a></li>\n<li><a href=\"/wiki/Doctor_of_Public_Health\" title=\"Doctor of Public Health\">Doctor of Public Health</a></li>\n<li><a href=\"/wiki/Professional_degrees_of_public_health\" title=\"Professional degrees of public health\">Professional degrees of public health</a></li>\n<li><a href=\"/wiki/Category:Schools_of_public_health\" title=\"Category:Schools of public health\">Schools of public health</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">History</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Sara_Josephine_Baker\" title=\"Sara Josephine Baker\">Sara Josephine Baker</a></li>\n<li><a href=\"/wiki/Samuel_Jay_Crumbine\" title=\"Samuel Jay Crumbine\">Samuel Jay Crumbine</a></li>\n<li><a href=\"/wiki/Carl_Rogers_Darnall\" title=\"Carl Rogers Darnall\">Carl Rogers Darnall</a></li>\n<li><a href=\"/wiki/Joseph_Lister\" title=\"Joseph Lister\">Joseph Lister</a></li>\n<li><a href=\"/wiki/Margaret_Sanger\" title=\"Margaret Sanger\">Margaret Sanger</a></li>\n<li><a href=\"/wiki/John_Snow_(physician)\" class=\"mw-redirect\" title=\"John Snow (physician)\">John Snow</a></li>\n<li><a href=\"/wiki/Mary_Mallon\" title=\"Mary Mallon\">Typhoid Mary</a></li>\n<li><a href=\"/wiki/Germ_theory_of_disease\" title=\"Germ theory of disease\">Germ theory of disease</a></li>\n<li><a href=\"/wiki/Social_hygiene_movement\" title=\"Social hygiene movement\">Social hygiene movement</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n<ul><li><img alt=\"Category\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" title=\"Category\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" data-file-width=\"36\" data-file-height=\"31\" /> <b><a href=\"/wiki/Category:Public_health\" title=\"Category:Public health\">Category</a></b></li>\n<li><img alt=\"Commons page\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/12px-Commons-logo.svg.png\" title=\"Commons page\" width=\"12\" height=\"16\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/18px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/24px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /> <b><a href=\"https://commons.wikimedia.org/wiki/Category:Public_health\" class=\"extiw\" title=\"commons:Category:Public health\">Commons</a></b></li>\n<li><img alt=\"WikiProject\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/16px-People_icon.svg.png\" title=\"WikiProject\" width=\"16\" height=\"16\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/24px-People_icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/37/People_icon.svg/32px-People_icon.svg.png 2x\" data-file-width=\"100\" data-file-height=\"100\" /> <b><a href=\"/wiki/Wikipedia:WikiProject_Nursing\" title=\"Wikipedia:WikiProject Nursing\">WikiProject</a></b></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2270\nCached time: 20180919152445\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.840 seconds\nReal time usage: 0.952 seconds\nPreprocessor visited node count: 6777/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 237590/2097152 bytes\nTemplate argument size: 27881/2097152 bytes\nHighest expansion depth: 13/40\nExpensive parser function count: 13/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 41035/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.419/10.000 seconds\nLua memory usage: 5.54 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  736.456      1 -total\n 31.97%  235.436      1 Template:Reflist\n 27.66%  203.684     28 Template:Fix\n 21.60%  159.067     21 Template:Citation_needed\n 19.02%  140.096     26 Template:Cite_web\n 16.54%  121.777     20 Template:Ambox\n 15.45%  113.773     28 Template:Delink\n 10.21%   75.211     51 Template:Category_handler\n  9.48%   69.798      2 Template:Multiple_issues\n  5.93%   43.666      7 Template:Refimprove\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1243554-0!canonical and timestamp 20180919152444 and revision id 857207539\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%B5%D9%8A%D8%AF%D9%84%D8%A9_%D8%A7%D8%AD%D8%AA%D8%B1%D8%A7%D8%B3%D9%8A%D8%A9","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0635\u064a\u062f\u0644\u0629 \u0627\u062d\u062a\u0631\u0627\u0633\u064a\u0629"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Farmacovigil%C3%A0ncia","langname":"Catalan","autonym":"catal\u00e0","*":"Farmacovigil\u00e0ncia"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Pharmakovigilanz","langname":"German","autonym":"Deutsch","*":"Pharmakovigilanz"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Farmacovigilancia","langname":"Spanish","autonym":"espa\u00f1ol","*":"Farmacovigilancia"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D9%85%D8%B1%D8%A7%D9%82%D8%A8%D8%AA%E2%80%8C%D9%87%D8%A7%DB%8C_%D8%AF%D8%A7%D8%B1%D9%88%DB%8C%DB%8C","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u0645\u0631\u0627\u0642\u0628\u062a\u200c\u0647\u0627\u06cc \u062f\u0627\u0631\u0648\u06cc\u06cc"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Pharmacovigilance","langname":"French","autonym":"fran\u00e7ais","*":"Pharmacovigilance"},{"lang":"hy","url":"https://hy.wikipedia.org/wiki/%D4%B4%D5%A5%D5%B2%D5%A1%D5%A6%D5%A3%D5%B8%D5%B6%D5%B8%D6%82%D5%A9%D5%B5%D5%B8%D6%82%D5%B6","langname":"Armenian","autonym":"\u0570\u0561\u0575\u0565\u0580\u0565\u0576","*":"\u0534\u0565\u0572\u0561\u0566\u0563\u0578\u0576\u0578\u0582\u0569\u0575\u0578\u0582\u0576"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Farmacovigilanza","langname":"Italian","autonym":"italiano","*":"Farmacovigilanza"},{"lang":"lv","url":"https://lv.wikipedia.org/wiki/Farmakovigilance","langname":"Latvian","autonym":"latvie\u0161u","*":"Farmakovigilance"},{"lang":"mk","url":"https://mk.wikipedia.org/wiki/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B2%D0%B8%D0%B3%D0%B8%D0%BB%D0%B0%D0%BD%D1%86%D0%B0","langname":"Macedonian","autonym":"\u043c\u0430\u043a\u0435\u0434\u043e\u043d\u0441\u043a\u0438","*":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0432\u0438\u0433\u0438\u043b\u0430\u043d\u0446\u0430"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Medicatiebewaking","langname":"Dutch","autonym":"Nederlands","*":"Medicatiebewaking"},{"lang":"sl","url":"https://sl.wikipedia.org/wiki/Farmakovigilanca","langname":"Slovenian","autonym":"sloven\u0161\u010dina","*":"Farmakovigilanca"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Farmakovigilans","langname":"Swedish","autonym":"svenska","*":"Farmakovigilans"},{"lang":"ta","url":"https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AE%B0%E0%AF%81%E0%AE%A8%E0%AF%8D%E0%AE%A4%E0%AE%BE%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AE%BF%E0%AE%AF%E0%AE%B2%E0%AF%8D_%E0%AE%95%E0%AE%A3%E0%AF%8D%E0%AE%95%E0%AE%BE%E0%AE%A3%E0%AE%BF%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81","langname":"Tamil","autonym":"\u0ba4\u0bae\u0bbf\u0bb4\u0bcd","*":"\u0bae\u0bb0\u0bc1\u0ba8\u0bcd\u0ba4\u0bbe\u0b95\u0bcd\u0b95\u0bbf\u0baf\u0bb2\u0bcd \u0b95\u0ba3\u0bcd\u0b95\u0bbe\u0ba3\u0bbf\u0baa\u0bcd\u0baa\u0bc1"},{"lang":"vi","url":"https://vi.wikipedia.org/wiki/C%E1%BA%A3nh_gi%C3%A1c_d%C6%B0%E1%BB%A3c","langname":"Vietnamese","autonym":"Ti\u1ebfng Vi\u1ec7t","*":"C\u1ea3nh gi\u00e1c d\u01b0\u1ee3c"}],"categories":[{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"","hidden":"","*":"CS1_French-language_sources_(fr)"},{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_March_2014"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_page_references_from_March_2014"},{"sortkey":"","hidden":"","*":"Articles_that_may_contain_original_research_from_March_2014"},{"sortkey":"","hidden":"","*":"All_articles_that_may_contain_original_research"},{"sortkey":"","hidden":"","*":"Articles_with_multiple_maintenance_issues"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_June_2017"},{"sortkey":"","hidden":"","*":"Articles_to_be_expanded_from_March_2014"},{"sortkey":"","hidden":"","*":"All_articles_to_be_expanded"},{"sortkey":"","hidden":"","*":"Articles_using_small_message_boxes"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_March_2014"},{"sortkey":"","hidden":"","*":"All_articles_with_vague_or_ambiguous_time"},{"sortkey":"","hidden":"","*":"Vague_or_ambiguous_time_from_March_2014"},{"sortkey":"","hidden":"","*":"Articles_with_incomplete_citations_from_March_2014"},{"sortkey":"","hidden":"","*":"All_articles_with_incomplete_citations"},{"sortkey":"","hidden":"","*":"All_Wikipedia_articles_needing_clarification"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_clarification_from_March_2014"},{"sortkey":"","hidden":"","*":"All_articles_with_specifically_marked_weasel-worded_phrases"},{"sortkey":"","hidden":"","*":"Articles_with_specifically_marked_weasel-worded_phrases_from_March_2014"},{"sortkey":"","hidden":"","*":"Articles_to_be_expanded_from_November_2013"},{"sortkey":"","hidden":"","*":"Articles_with_empty_sections_from_November_2013"},{"sortkey":"","hidden":"","*":"All_articles_with_empty_sections"},{"sortkey":"","*":"Clinical_research"},{"sortkey":"","*":"Clinical_trials"},{"sortkey":" ","*":"Drug_safety"},{"sortkey":"","*":"Healthcare_quality"},{"sortkey":"","*":"Pharmaceuticals_policy"}],"links":[{"ns":0,"exists":"","*":"Drug safety"},{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"Adverse effect (medicine)"},{"ns":0,"exists":"","*":"Adverse event"},{"ns":0,"exists":"","*":"Analysis of variance"},{"ns":0,"exists":"","*":"Asymptomatic carrier"},{"ns":0,"exists":"","*":"Auxology"},{"ns":0,"exists":"","*":"BRCA1"},{"ns":0,"exists":"","*":"Bachelor of Science in Public Health"},{"ns":0,"exists":"","*":"Behavior change (public health)"},{"ns":0,"exists":"","*":"Behavioural change theories"},{"ns":0,"exists":"","*":"Biological hazard"},{"ns":0,"exists":"","*":"Biostatistics"},{"ns":0,"exists":"","*":"Black triangle (pharmacovigilance)"},{"ns":0,"exists":"","*":"Boston Collaborative Drug Surveillance Program"},{"ns":0,"exists":"","*":"COSTART"},{"ns":0,"exists":"","*":"Cardiac pacemakers"},{"ns":0,"exists":"","*":"Carl Rogers Darnall"},{"ns":0,"exists":"","*":"Case\u2013control study"},{"ns":0,"exists":"","*":"Causal relationship"},{"ns":0,"exists":"","*":"Centers for Disease Control and Prevention"},{"ns":0,"exists":"","*":"Chief Medical Officer"},{"ns":0,"exists":"","*":"Child mortality"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Clinical trials"},{"ns":0,"exists":"","*":"Code of Federal Regulations"},{"ns":0,"exists":"","*":"Community health"},{"ns":0,"exists":"","*":"Consultant pharmacist"},{"ns":0,"exists":"","*":"Council on Education for Public Health"},{"ns":0,"exists":"","*":"Cultural competence in health care"},{"ns":0,"exists":"","*":"Deviance (sociology)"},{"ns":0,"exists":"","*":"Diffusion of innovations"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Directive 2001/20/EC"},{"ns":0,"exists":"","*":"Directive 2001/83/EC"},{"ns":0,"exists":"","*":"Disease surveillance"},{"ns":0,"exists":"","*":"Doctor of Public Health"},{"ns":0,"exists":"","*":"Drug"},{"ns":0,"exists":"","*":"DrugLogic"},{"ns":0,"exists":"","*":"Drug Safety"},{"ns":0,"exists":"","*":"Effectiveness"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Emergency sanitation"},{"ns":0,"exists":"","*":"Environmental health"},{"ns":0,"exists":"","*":"Epidemic"},{"ns":0,"exists":"","*":"Epidemiology"},{"ns":0,"exists":"","*":"Etymological"},{"ns":0,"exists":"","*":"EudraVigilance"},{"ns":0,"exists":"","*":"European Centre for Disease Prevention and Control"},{"ns":0,"exists":"","*":"European Community"},{"ns":0,"exists":"","*":"European Free Trade Association"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"European Parliament Committee on the Environment, Public Health and Food Safety"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"Euthenics"},{"ns":0,"exists":"","*":"Family planning"},{"ns":0,"exists":"","*":"Fecal\u2013oral route"},{"ns":0,"exists":"","*":"Food additive"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Food and Drug Administration (United States)"},{"ns":0,"exists":"","*":"Food chemistry"},{"ns":0,"exists":"","*":"Food engineering"},{"ns":0,"exists":"","*":"Food microbiology"},{"ns":0,"exists":"","*":"Food processing"},{"ns":0,"exists":"","*":"Food safety"},{"ns":0,"exists":"","*":"Genetically modified food"},{"ns":0,"exists":"","*":"Germ theory of disease"},{"ns":0,"exists":"","*":"Global health"},{"ns":0,"exists":"","*":"Globalization and disease"},{"ns":0,"exists":"","*":"Good agricultural practice"},{"ns":0,"exists":"","*":"Good manufacturing practice"},{"ns":0,"exists":"","*":"HACCP"},{"ns":0,"exists":"","*":"Hand washing"},{"ns":0,"exists":"","*":"Harm"},{"ns":0,"exists":"","*":"Health Canada"},{"ns":0,"exists":"","*":"Health belief model"},{"ns":0,"exists":"","*":"Health benefit (medicine)"},{"ns":0,"exists":"","*":"Health care reform"},{"ns":0,"exists":"","*":"Health communication"},{"ns":0,"exists":"","*":"Health economics"},{"ns":0,"exists":"","*":"Health education"},{"ns":0,"exists":"","*":"Health equity"},{"ns":0,"exists":"","*":"Health impact assessment"},{"ns":0,"exists":"","*":"Health literacy"},{"ns":0,"exists":"","*":"Health policy"},{"ns":0,"exists":"","*":"Health promotion"},{"ns":0,"exists":"","*":"Health psychology"},{"ns":0,"exists":"","*":"Health system"},{"ns":0,"exists":"","*":"Herbal products"},{"ns":0,"exists":"","*":"Human factors and ergonomics"},{"ns":0,"exists":"","*":"Human nutrition"},{"ns":0,"exists":"","*":"Hygiene"},{"ns":0,"exists":"","*":"ISO 22000"},{"ns":0,"exists":"","*":"Infant mortality"},{"ns":0,"exists":"","*":"Infection control"},{"ns":0,"exists":"","*":"Injury prevention"},{"ns":0,"exists":"","*":"International Society for Pharmacoepidemiology"},{"ns":0,"exists":"","*":"International Society of Pharmacovigilance"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"John Snow (physician)"},{"ns":0,"exists":"","*":"Joseph Lister"},{"ns":0,"exists":"","*":"List of epidemics"},{"ns":0,"exists":"","*":"List of notifiable diseases"},{"ns":0,"exists":"","*":"List of open-source health software"},{"ns":0,"exists":"","*":"List of statistical packages"},{"ns":0,"exists":"","*":"List of withdrawn drugs"},{"ns":0,"exists":"","*":"MHLW"},{"ns":0,"exists":"","*":"Margaret Sanger"},{"ns":0,"exists":"","*":"Mary Mallon"},{"ns":0,"exists":"","*":"Maternal health"},{"ns":0,"exists":"","*":"MedDRA"},{"ns":0,"exists":"","*":"MedWatch"},{"ns":0,"exists":"","*":"Medical anthropology"},{"ns":0,"exists":"","*":"Medical device"},{"ns":0,"exists":"","*":"Medical literature"},{"ns":0,"exists":"","*":"Medical robots"},{"ns":0,"exists":"","*":"Medical sociology"},{"ns":0,"exists":"","*":"Medication error"},{"ns":0,"exists":"","*":"Mental health"},{"ns":0,"exists":"","*":"Ministry of Health and Family Welfare"},{"ns":0,"exists":"","*":"Myocardial infarction"},{"ns":0,"exists":"","*":"National Drug & Safety League"},{"ns":0,"exists":"","*":"Neuroprosthetics"},{"ns":0,"exists":"","*":"Notifiable disease"},{"ns":0,"exists":"","*":"Occupational health nursing"},{"ns":0,"exists":"","*":"Occupational hygiene"},{"ns":0,"exists":"","*":"Occupational medicine"},{"ns":0,"exists":"","*":"Occupational safety and health"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Open defecation"},{"ns":0,"exists":"","*":"Oral hygiene"},{"ns":0,"exists":"","*":"PRECEDE-PROCEED model"},{"ns":0,"exists":"","*":"Patient safety"},{"ns":0,"exists":"","*":"Patient safety organization"},{"ns":0,"exists":"","*":"Pharmaceutical drug"},{"ns":0,"exists":"","*":"Pharmaceutical policy"},{"ns":0,"exists":"","*":"Pharmaceuticals and Medical Devices Agency"},{"ns":0,"exists":"","*":"Pharmaceuticals and personal care products in the environment"},{"ns":0,"exists":"","*":"Pharmacoepidemiology"},{"ns":0,"exists":"","*":"Pharmacogenetics"},{"ns":0,"exists":"","*":"Pharmacogenomics"},{"ns":0,"exists":"","*":"Pharmacology"},{"ns":0,"exists":"","*":"Pharmacotherapy"},{"ns":0,"exists":"","*":"Pharmacy and Poisons Board"},{"ns":0,"exists":"","*":"Phases of clinical research"},{"ns":0,"exists":"","*":"Population health"},{"ns":0,"exists":"","*":"Positive deviance"},{"ns":0,"exists":"","*":"Preventive healthcare"},{"ns":0,"exists":"","*":"Preventive nutrition"},{"ns":0,"exists":"","*":"Professional degrees of public health"},{"ns":0,"exists":"","*":"Prophylaxis"},{"ns":0,"exists":"","*":"Proportional reporting ratio"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Public Citizen"},{"ns":0,"exists":"","*":"Public health"},{"ns":0,"exists":"","*":"Public health genomics"},{"ns":0,"exists":"","*":"Public health informatics"},{"ns":0,"exists":"","*":"Public health intervention"},{"ns":0,"exists":"","*":"Public health laboratory"},{"ns":0,"exists":"","*":"Public health law"},{"ns":0,"exists":"","*":"Public health surveillance"},{"ns":0,"exists":"","*":"Qualified Person for Pharmacovigilance"},{"ns":0,"exists":"","*":"Quarantine"},{"ns":0,"exists":"","*":"ROC curve"},{"ns":0,"exists":"","*":"Race and health"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Rechallenge"},{"ns":0,"exists":"","*":"Regression analysis"},{"ns":0,"exists":"","*":"Regulation"},{"ns":0,"exists":"","*":"Regulation of therapeutic goods in the United States"},{"ns":0,"exists":"","*":"Relative risk"},{"ns":0,"exists":"","*":"Reproductive health"},{"ns":0,"exists":"","*":"Republic of Korea"},{"ns":0,"exists":"","*":"Research on Adverse Drug events And Reports"},{"ns":0,"exists":"","*":"Risk"},{"ns":0,"exists":"","*":"Risk factor"},{"ns":0,"exists":"","*":"Risk management"},{"ns":0,"exists":"","*":"Risk management plan"},{"ns":0,"exists":"","*":"Safe sex"},{"ns":0,"exists":"","*":"Samuel Jay Crumbine"},{"ns":0,"exists":"","*":"Sanitary sewer"},{"ns":0,"exists":"","*":"Sanitation"},{"ns":0,"exists":"","*":"Sara Josephine Baker"},{"ns":0,"exists":"","*":"Science"},{"ns":0,"exists":"","*":"Sexually transmitted infection"},{"ns":0,"exists":"","*":"Signal detection"},{"ns":0,"exists":"","*":"Smoking cessation"},{"ns":0,"exists":"","*":"Social cognitive theory"},{"ns":0,"exists":"","*":"Social determinants of health"},{"ns":0,"exists":"","*":"Social hygiene movement"},{"ns":0,"exists":"","*":"Social medicine"},{"ns":0,"exists":"","*":"Social norms approach"},{"ns":0,"exists":"","*":"Social psychology"},{"ns":0,"exists":"","*":"Society of Pharmacovigilance, India"},{"ns":0,"exists":"","*":"Sociology of health and illness"},{"ns":0,"exists":"","*":"Statistical hypothesis testing"},{"ns":0,"exists":"","*":"Student's t-test"},{"ns":0,"exists":"","*":"Syed Ziaur Rahman"},{"ns":0,"exists":"","*":"Theory of planned behavior"},{"ns":0,"exists":"","*":"Therapeutic"},{"ns":0,"exists":"","*":"Thermometers"},{"ns":0,"exists":"","*":"Think tank"},{"ns":0,"exists":"","*":"Tongue depressors"},{"ns":0,"exists":"","*":"Traditional medicines"},{"ns":0,"exists":"","*":"Transtheoretical model"},{"ns":0,"exists":"","*":"Triage"},{"ns":0,"exists":"","*":"Tropical disease"},{"ns":0,"exists":"","*":"United States Public Health Service"},{"ns":0,"exists":"","*":"University of Nairobi"},{"ns":0,"exists":"","*":"Uppsala Monitoring Centre"},{"ns":0,"exists":"","*":"Vaccination"},{"ns":0,"exists":"","*":"Vaccine trial"},{"ns":0,"exists":"","*":"Vector control"},{"ns":0,"exists":"","*":"VigiBase"},{"ns":0,"exists":"","*":"WHOART"},{"ns":0,"exists":"","*":"Waterborne diseases"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"exists":"","*":"World Toilet Organization"},{"ns":0,"exists":"","*":"Yellow Card Scheme"},{"ns":0,"exists":"","*":"Z-test"},{"ns":0,"*":"Department of Pharmacology and Pharmacognosy"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from March 2014"},{"ns":14,"exists":"","*":"Category:Articles lacking page references from March 2014"},{"ns":14,"exists":"","*":"Category:Articles that may contain original research from March 2014"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from June 2017"},{"ns":14,"exists":"","*":"Category:Articles to be expanded from March 2014"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from March 2014"},{"ns":14,"exists":"","*":"Category:Vague or ambiguous time from March 2014"},{"ns":14,"exists":"","*":"Category:Articles with incomplete citations from March 2014"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing clarification from March 2014"},{"ns":14,"exists":"","*":"Category:Articles with specifically marked weasel-worded phrases from March 2014"},{"ns":14,"exists":"","*":"Category:Articles to be expanded from November 2013"},{"ns":14,"exists":"","*":"Category:Articles with empty sections from November 2013"},{"ns":14,"exists":"","*":"Category:City and county health departments in the United States"},{"ns":14,"exists":"","*":"Category:Food safety scandals"},{"ns":14,"exists":"","*":"Category:Public health"},{"ns":14,"exists":"","*":"Category:Schools of public health"},{"ns":10,"exists":"","*":"Template:Public health"},{"ns":1,"exists":"","*":"Talk:Pharmacovigilance"},{"ns":4,"exists":"","*":"Wikipedia:Avoid weasel words"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style/Dates and numbers"},{"ns":4,"exists":"","*":"Wikipedia:No original research"},{"ns":4,"exists":"","*":"Wikipedia:Vagueness"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":4,"exists":"","*":"Wikipedia:WikiProject Fact and Reference Check"},{"ns":4,"exists":"","*":"Wikipedia:WikiProject Nursing"},{"ns":11,"exists":"","*":"Template talk:Public health"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Redirect"},{"ns":10,"exists":"","*":"Template:Multiple issues"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Refimprove"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Page numbers improve"},{"ns":10,"exists":"","*":"Template:Original research"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Unreferenced section"},{"ns":10,"exists":"","*":"Template:Unreferenced"},{"ns":10,"exists":"","*":"Template:Refimprove section"},{"ns":10,"exists":"","*":"Template:Cn"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Expand section"},{"ns":10,"exists":"","*":"Template:When"},{"ns":10,"exists":"","*":"Template:See also"},{"ns":10,"exists":"","*":"Template:Full citation needed"},{"ns":10,"exists":"","*":"Template:Vague"},{"ns":10,"exists":"","*":"Template:Which"},{"ns":10,"exists":"","*":"Template:Empty section"},{"ns":10,"exists":"","*":"Template:Div col"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Div col end"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Wiktionary"},{"ns":10,"exists":"","*":"Template:Sister project"},{"ns":10,"exists":"","*":"Template:Side box"},{"ns":10,"exists":"","*":"Template:Public health"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Icon"},{"ns":828,"exists":"","*":"Module:Redirect hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Redirect"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:Labelled list hatnote"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Side box"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Icon"},{"ns":828,"exists":"","*":"Module:Icon/data"},{"ns":0,"exists":"","*":"Drug safety"}],"images":["Lock-green.svg","Ambox_important.svg","Question_book-new.svg","Text_document_with_page_number_icon.svg","Wiki_letter_w_cropped.svg","Wiktionary-logo-en-v2.svg","Folder_Hexagonal_Icon.svg","Commons-logo.svg","People_icon.svg"],"externallinks":["http://ec.europa.eu/health/files/eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf","https://www.who-umc.org/media/2680/who-technical-report-498.pdf","http://sjpharmaco.com/Preparing%20for%20a%20Pharmacovigilance%20Safety%20Inspection.pdf","http://www.acrin.org/Portals/0/Administration/Regulatory/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf","http://www.ich.org/cache/compo/475-272-1.html","https://web.archive.org/web/20101110015452/http://www.ich.org/cache/compo/475-272-1.html","http://estri.ich.org/new-icsr/index.htm","https://web.archive.org/web/20100823124028/http://estri.ich.org/new-icsr/index.htm","http://www.who-umc.org/DynPage.aspx?id=13140&mn=1514","http://ireminder.com/products/medtrigger","https://www.who-umc.org/global-pharmacovigilance/who-programme","https://www.who-umc.org/global-pharmacovigilance/who-programme/being-a-member/","http://www.ich.org/about/organisation-of-ich.html","https://web.archive.org/web/20150227142309/http://www.ich.org/about/organisation-of-ich/steering.html","http://www.ich.org/about/organisation-of-ich/steering.html","http://www.isoponline.org/","http://apps.who.int/medicinedocs/en/d/Js4893e/3.html","https://www.forbes.com/sites/matthewherper/2012/07/12/the-global-drug-market-will-swell-to-1-2-trillion-while-big-pharma-treads-water/","http://www.clinicalleader.com/doc/chinas-pharmacovigilance-system-the-hunger-0001","http://www.biopharminternational.com/biopharm/article/articleDetail.jsp?id=810540&sk=&date=&pageID=3","https://link.springer.com/article/10.1007/BF03262389","//doi.org/10.1007/bf03262389","http://www.paho.org/hq/index.php?option=com_content&view=category&layout=blog&id=1156&Itemid=513","http://www.ipc.gov.in","http://www.cdsco.nic.in","http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000456.jsp&mid=WC0b01ac05801ae8fb","http://heads.medagencies.org/","http://www.bnds.fr/revue/rgdm/panorama-de-droit-pharmaceutique-2015/pharmacovigilance-europeenne-un-systeme-aux-multiples-visages-6101.html","https://web.archive.org/web/20150227141047/http://se-fc.org/gestor/farmacovigilancia/generalidades.html","http://se-fc.org/gestor/farmacovigilancia/generalidades.html","https://www.swissmedic.ch/bewilligungen/00155/00242/00327/00345/index.html?lang=en","http://www.pv.pharmacyboardkenya.org","http://pharmacology.uonbi.ac.ke//uon_degrees_details/751","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3691479","//doi.org/10.1007/s40264-013-0049-3","//www.ncbi.nlm.nih.gov/pubmed/23620169","http://www.ijp-online.com/text.asp?2006/38/4/229/27017","//doi.org/10.4103/0253-7613.27017","//doi.org/10.1016/j.envint.2008.05.002","http://www.ehjournal.net/content/6/1/20","//doi.org/10.1186/1476-069X-6-20","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1947975","//www.ncbi.nlm.nih.gov/pubmed/17650313","http://www.fda.gov/Safety/MedWatch/HowToReport/ucm085568.htm","https://web.archive.org/web/20060924192651/http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=368","http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126834.pdf","http://medsfacts.com","http://ec.europa.eu/health/documents/eudralex/vol-9/index_en.htm"],"sections":[{"toclevel":1,"level":"2","line":"Terms commonly used in drug safety","number":"1","index":"1","fromtitle":"Pharmacovigilance","byteoffset":2970,"anchor":"Terms_commonly_used_in_drug_safety"},{"toclevel":1,"level":"2","line":"Adverse event reporting","number":"2","index":"2","fromtitle":"Pharmacovigilance","byteoffset":7811,"anchor":"Adverse_event_reporting"},{"toclevel":2,"level":"3","line":"Individual Case Safety Report (ICSR)","number":"2.1","index":"3","fromtitle":"Pharmacovigilance","byteoffset":9025,"anchor":"Individual_Case_Safety_Report_(ICSR)"},{"toclevel":2,"level":"3","line":"Coding of adverse events","number":"2.2","index":"4","fromtitle":"Pharmacovigilance","byteoffset":11945,"anchor":"Coding_of_adverse_events"},{"toclevel":2,"level":"3","line":"Seriousness determination","number":"2.3","index":"5","fromtitle":"Pharmacovigilance","byteoffset":12962,"anchor":"Seriousness_determination"},{"toclevel":2,"level":"3","line":"Expedited reporting","number":"2.4","index":"6","fromtitle":"Pharmacovigilance","byteoffset":15642,"anchor":"Expedited_reporting"},{"toclevel":2,"level":"3","line":"Clinical trial reporting","number":"2.5","index":"7","fromtitle":"Pharmacovigilance","byteoffset":16578,"anchor":"Clinical_trial_reporting"},{"toclevel":2,"level":"3","line":"Spontaneous reporting","number":"2.6","index":"8","fromtitle":"Pharmacovigilance","byteoffset":17519,"anchor":"Spontaneous_reporting"},{"toclevel":2,"level":"3","line":"Aggregate reporting","number":"2.7","index":"9","fromtitle":"Pharmacovigilance","byteoffset":21547,"anchor":"Aggregate_reporting"},{"toclevel":2,"level":"3","line":"Other reporting methods","number":"2.8","index":"10","fromtitle":"Pharmacovigilance","byteoffset":22610,"anchor":"Other_reporting_methods"},{"toclevel":1,"level":"2","line":"Risk management","number":"3","index":"11","fromtitle":"Pharmacovigilance","byteoffset":23213,"anchor":"Risk_management"},{"toclevel":2,"level":"3","line":"Causality assessment","number":"3.1","index":"12","fromtitle":"Pharmacovigilance","byteoffset":23725,"anchor":"Causality_assessment"},{"toclevel":2,"level":"3","line":"Signal detection","number":"3.2","index":"13","fromtitle":"Pharmacovigilance","byteoffset":26732,"anchor":"Signal_detection"},{"toclevel":2,"level":"3","line":"Risk management plans","number":"3.3","index":"14","fromtitle":"Pharmacovigilance","byteoffset":28388,"anchor":"Risk_management_plans"},{"toclevel":2,"level":"3","line":"Risk/benefit profile of drugs","number":"3.4","index":"15","fromtitle":"Pharmacovigilance","byteoffset":30830,"anchor":"Risk/benefit_profile_of_drugs"},{"toclevel":2,"level":"3","line":"Pharmacoepidemiology","number":"3.5","index":"16","fromtitle":"Pharmacovigilance","byteoffset":32975,"anchor":"Pharmacoepidemiology"},{"toclevel":2,"level":"3","line":"Pharmacogenetics and pharmacogenomics","number":"3.6","index":"17","fromtitle":"Pharmacovigilance","byteoffset":33348,"anchor":"Pharmacogenetics_and_pharmacogenomics"},{"toclevel":1,"level":"2","line":"International collaboration","number":"4","index":"18","fromtitle":"Pharmacovigilance","byteoffset":34056,"anchor":"International_collaboration"},{"toclevel":2,"level":"3","line":"The World Health Organization (WHO)","number":"4.1","index":"19","fromtitle":"Pharmacovigilance","byteoffset":34232,"anchor":"The_World_Health_Organization_(WHO)"},{"toclevel":2,"level":"3","line":"The International Council for Harmonisation (ICH)","number":"4.2","index":"20","fromtitle":"Pharmacovigilance","byteoffset":35556,"anchor":"The_International_Council_for_Harmonisation_(ICH)"},{"toclevel":2,"level":"3","line":"The Council for International Organizations of Medical Science (CIOMS)","number":"4.3","index":"21","fromtitle":"Pharmacovigilance","byteoffset":37117,"anchor":"The_Council_for_International_Organizations_of_Medical_Science_(CIOMS)"},{"toclevel":2,"level":"3","line":"The International Society of Pharmacovigilance (ISoP)","number":"4.4","index":"22","fromtitle":"Pharmacovigilance","byteoffset":38087,"anchor":"The_International_Society_of_Pharmacovigilance_(ISoP)"},{"toclevel":1,"level":"2","line":"Regulatory authorities","number":"5","index":"23","fromtitle":"Pharmacovigilance","byteoffset":38927,"anchor":"Regulatory_authorities"},{"toclevel":2,"level":"3","line":"United States","number":"5.1","index":"24","fromtitle":"Pharmacovigilance","byteoffset":39560,"anchor":"United_States"},{"toclevel":2,"level":"3","line":"Emerging economies (including Latin America)","number":"5.2","index":"25","fromtitle":"Pharmacovigilance","byteoffset":40789,"anchor":"Emerging_economies_(including_Latin_America)"},{"toclevel":2,"level":"3","line":"European Union","number":"5.3","index":"26","fromtitle":"Pharmacovigilance","byteoffset":44693,"anchor":"European_Union"},{"toclevel":2,"level":"3","line":"Rest of Europe, including non-EU","number":"5.4","index":"27","fromtitle":"Pharmacovigilance","byteoffset":47618,"anchor":"Rest_of_Europe,_including_non-EU"},{"toclevel":2,"level":"3","line":"Japan","number":"5.5","index":"28","fromtitle":"Pharmacovigilance","byteoffset":48284,"anchor":"Japan"},{"toclevel":2,"level":"3","line":"Canada","number":"5.6","index":"29","fromtitle":"Pharmacovigilance","byteoffset":48603,"anchor":"Canada"},{"toclevel":2,"level":"3","line":"South Korea","number":"5.7","index":"30","fromtitle":"Pharmacovigilance","byteoffset":48895,"anchor":"South_Korea"},{"toclevel":2,"level":"3","line":"Africa","number":"5.8","index":"31","fromtitle":"Pharmacovigilance","byteoffset":49237,"anchor":"Africa"},{"toclevel":3,"level":"4","line":"Kenya","number":"5.8.1","index":"32","fromtitle":"Pharmacovigilance","byteoffset":49251,"anchor":"Kenya"},{"toclevel":2,"level":"3","line":"Rest of world (ROW)","number":"5.9","index":"33","fromtitle":"Pharmacovigilance","byteoffset":50242,"anchor":"Rest_of_world_(ROW)"},{"toclevel":1,"level":"2","line":"Pharmacoenvironmentology; (Ecopharmacovigilance [EPV])","number":"6","index":"34","fromtitle":"Pharmacovigilance","byteoffset":50583,"anchor":"Pharmacoenvironmentology;_(Ecopharmacovigilance_[EPV])"},{"toclevel":1,"level":"2","line":"Related to medical devices","number":"7","index":"35","fromtitle":"Pharmacovigilance","byteoffset":54319,"anchor":"Related_to_medical_devices"},{"toclevel":1,"level":"2","line":"For herbal medicines","number":"8","index":"36","fromtitle":"Pharmacovigilance","byteoffset":56588,"anchor":"For_herbal_medicines"},{"toclevel":1,"level":"2","line":"Industry associations","number":"9","index":"37","fromtitle":"Pharmacovigilance","byteoffset":58196,"anchor":"Industry_associations"},{"toclevel":1,"level":"2","line":"See also","number":"10","index":"38","fromtitle":"Pharmacovigilance","byteoffset":58260,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"11","index":"39","fromtitle":"Pharmacovigilance","byteoffset":59291,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"12","index":"40","fromtitle":"Pharmacovigilance","byteoffset":59333,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Pharmacovigilance","iwlinks":[{"prefix":"wiktionary","url":"https://en.wiktionary.org/wiki/Special:Search/pharmacovigilance","*":"wiktionary:Special:Search/pharmacovigilance"},{"prefix":"commons","url":"https://commons.wikimedia.org/wiki/Category:Public_health","*":"commons:Category:Public health"}],"properties":[{"name":"wikibase_item","*":"Q1550789"}]}}